World-Leading CAR-T Therapy, Robotic Cancer Surgery, Proton/Heavy-Ion & Executive Healthcare in China for Middle Eastern Patients
Direct priority admission into China's top 16 JCI and Class-A Tertiary (San-Jia) National Medical Centers in Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, and Hainan Boao Lecheng. Experience unmatched surgical volumes, 12-day vein-to-vein CAR-T manufacturing, Da Vinci SP & Toumai surgical robotics, curative "Beijing Protocol" stem cell transplants for Thalassemia & Leukemia, and 100% Halal-certified Arabic VIP hospital hospitality—at 50% to 75% lower cost than the US or Europe.
Dedicated one-on-one reception from aircraft door to VIP hospital suite. Our senior Chinese professors and native Arabic medical coordinators accompany every patient and family throughout diagnosis, surgery, cellular therapy, and convalescence.
Inside China's Accredited International Medical Wings, Particle Accelerators & Robotic Suites
360° synchrotron particle beam gantry at SPHIC Shanghai for chordoma, sarcoma, liver, pancreatic, and prostate tumors.
30-day visa-free tropical medical island in Hainan with special franchise for immediate FDA/EMA-approved orphan drugs & BNCT.
Biplane DSA + open surgical theater at Fuwai & Tiantan Hospitals for Sun's aortic arch procedure, TAVR, and giant aneurysm bypass.
Dedicated Arabic/English diplomatic reception handling MOH letters of guarantee, private insurance GOP, and PSB visa extensions.
Why Patients & Royal Medical Offices Across the Middle East Choose China for Complex Medical Care
Over the past decade, China's premier national medical centers in Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, and the Hainan Boao Lecheng International Medical Tourism Pilot Zone have emerged as global referral destinations for patients from Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman, Bahrain, Jordan, Egypt, and Iraq. Driven by unmatched clinical case volumes, state-supported biotechnology breakthroughs in cellular immunotherapy, ultra-high-precision surgical robotics, and deep cultural respect for Islamic traditions, the Sino-Gulf Medical Corridor delivers clinical outcomes that rival or surpass top North American and European centers—at 40% to 75% lower total cost and with zero multi-month waiting lists.
In surgical oncology, cardiovascular reconstruction, organ transplantation, and neurosurgery, clinical excellence is directly correlated with surgical volume. While a typical Western tertiary hospital may perform 40 to 60 pancreaticoduodenectomies (Whipple procedures) or 30 aortic arch replacements annually, China's top Class-A Tertiary (San-Jia) academic medical centers routinely perform 500 to 1,200+ complex hepatobiliary/pancreatic resections and over 1,500 complex aortic and cardiac valve interventions per hospital each year. This concentration of clinical experience translates into shorter anesthesia times, minimal intraoperative blood loss, lower complication rates, and superior long-term survival for high-risk patients who have been deemed "inoperable" or "treatment-refractory" elsewhere.
Equally transformative is China's leadership in Chimeric Antigen Receptor T-Cell (CAR-T) therapy, gene therapy, and regenerative medicine. With six NMPA-approved commercial CAR-T products and the world's largest portfolio of dual-target and solid-tumor cellular immunotherapy clinical programs (targeting CD19, BCMA, CD22, CD7, GPRC5D, Claudin18.2, and GPC3), patients from the Arabian Gulf gain immediate access to life-saving cellular therapies within 72 hours of arrival, supported by dedicated Arabic-speaking medical concierges, Halal-certified hospital nutrition, private family recovery suites, and seamless international insurance coordination.
Unmatched Surgical & Clinical Volume
Senior department directors at PUMCH, Ruijin, Zhongshan, Huashan, Fuwai, Tiantan, and Sun Yat-sen University Cancer Center personally lead complex surgeries with 5,000+ career procedure track records.
48-Hour Tele-MDT & Zero Waitlists
Direct green-channel admission into VIP International Wings (IMS). PET-CT, 3.0T/5.0T MRI, genomic sequencing, and multidisciplinary tumor board (MDT) consultations are completed within 48 to 72 hours.
Tailored for GCC & Arab Families
Certified native Arabic/English medical interpreters, strictly Halal inpatient dining, Qibla-marked prayer spaces, gender-concordant nursing for female patients, and spacious multi-room VIP family suites.
Direct Flights & Visa-Free Access
6.5 to 8.5 hour direct flights from Riyadh, Jeddah, Dubai, Abu Dhabi, Doha, Kuwait, Muscat, and Cairo. 30-day visa-free entry for GCC citizens plus 48-hour emergency medical visa support.
Before a patient even boards a flight from Riyadh, Dubai, Doha, or Kuwait City, our senior Chinese oncology, surgical, radiology, and cellular therapy professors convene a live video MDT session with the patient's family and local attending physicians to establish a definitive diagnostic and therapeutic roadmap.
| Clinical & Logistical Metric | China Top Tertiary / JCI | USA / UK / Germany |
|---|---|---|
| Wait Time for Specialist MDT & PET-CT | 24 – 72 Hours | 3 – 8 Weeks |
| Wait Time for Major Oncology Surgery | 3 – 5 Days Post-Admission | 4 – 10 Weeks |
| Commercial / Clinical CAR-T Therapy Cost | $45,000 – $165,000 USD | $450,000 – $680,000 USD |
| Da Vinci Xi / SP Robotic Cancer Surgery | $14,000 – $26,000 USD | $65,000 – $145,000 USD |
| Proton & Carbon Heavy Ion Therapy (Full Course) | $38,000 – $48,000 USD | $120,000 – $220,000 USD |
| Executive Whole-Body PET-MRI / 3.0T Checkup | $1,800 – $4,800 USD | $12,000 – $28,000 USD |
| GCC Visa Requirement (UAE, Qatar, KSA, Oman, Bahrain) | 30-Day Visa-Free / 48h Express | 2 – 6 Weeks Embassy Interview |
Comprehensive Medical Checkup Packages & Itemized Diagnostic Catalog
Early sub-millimeter detection saves lives. Our partner international medical centers deploy the world's most advanced diagnostic imaging, liquid biopsy, and functional profiling technologies—including Total-Body uEXPLORER PET-CT, 3.0T & 5.0T Ultra-High-Field MRI, Dual-Source Photon-Counting Coronary CT, Magnetically Controlled Capsule Endoscopy, and Whole-Genome Sequencing. Below is our complete catalog of executive checkup packages and individual diagnostic modalities, with interactive selection to build a custom screening itinerary via WhatsApp.
Total-Body PET-CT, PET-MRI & 5.0T High-Field MRI Suite
Equipped with United Imaging uEXPLORER Total-Body PET-CT (capable of scanning the entire human body in a single 15-second breath-hold at 1/40th the radiation dose of conventional scanners) alongside Siemens Magnetom Prisma 3.0T and uMR Jupiter 5.0T ultra-high-field MRI systems.
Interactive Checkup & Diagnostic Configurator
Filter by diagnostic category or click "+ Add to Checkup Plan" on any test below to generate a personalized quotation and schedule via WhatsApp.
Part A: All-Inclusive Executive & Royal Medical Checkup Packages (1 to 3 Days)
1. Royal Diamond Pan-Cancer, Cardiac & Longevity Inpatient Suite
Designed for royal family members, senior executives, and patients with a family history of cancer or cardiovascular disease. Conducted entirely inside a private VIP hospital suite with a dedicated Arabic interpreter and 1-on-1 nursing escort so the patient rarely leaves their private floor.
- • Total-Body Low-Dose PET-CT OR Whole-Body Diffusion MRI + 3.0T Brain MRI/MRA for sub-2mm tumor and aneurysm detection.
- • Dual-Source 640-Slice Coronary CT Angiography (CCTA) with FFR-CT hemodynamic fractional flow reserve analysis.
- • Painless Propofol-Sedated Magnifying NBI Gastroscopy & Colonoscopy with immediate endoscopic polypectomy if needed.
- • Liquid Biopsy (ctDNA Methylation Screening for 50+ Cancers) + Whole-Exome Hereditary Oncology & Pharmacogenomics (180+ drug metabolism genes).
- • 120-Biomarker Blood, Endocrine, Heavy Metal, Immune Repertoire (T/B/NK lymphocyte subsets) & FibroScan Liver Assessment.
- • 90-Minute Private Consultation with Chief Internist, Oncologist, Cardiologist, and Senior TCM Master for personalized longevity prescription.
2. Ultra-Early Molecular Oncology & Dual-Tracer PET Screening
Specifically engineered for cancer survivors monitoring for minimal residual disease (MRD), high-risk individuals with elevated tumor markers, or patients seeking definitive staging of indeterminate pulmonary nodules, liver lesions, or lymphadenopathy.
- • Dual-Tracer PET-CT (18F-FDG + 68Ga-FAPI-04 or 68Ga-PSMA) to detect fibroblast activation in gastric, pancreatic, hepatobiliary, breast, and prostate micro-lesions often missed by standard FDG scans.
- • Circulating Tumor Cell (CTC) Enumeration & ctDNA Ultra-Deep Sequencing across 500+ driver mutations (EGFR, ALK, KRAS, BRCA1/2, PIK3CA, TP53).
- • High-Resolution 3.0T Multiparametric Organ MRI (targeted to Brain, Liver with Primovist hepatobiliary contrast, Pancreas MRCP, Breast, or Multiparametric Prostate).
- • 24-Marker Serum Tumor Panel (AFP, AFP-L3, PIVKA-II, CEA, CA19-9, CA125, HE4, CA15-3, CA72-4, CYFRA21-1, NSE, ProGRP, SCC, Total/Free PSA, ProPSA/PHI).
- • High-Frequency Ultrasound of Thyroid, Cervical/Axillary/Inguinal Lymph Nodes, Abdomen, and Pelvis by Senior Sonographer.
3. Pan-Vascular Cardio-Cerebral Stroke & Infarction Prevention
Tailored for Middle Eastern patients managing hypertension, diabetes mellitus, dyslipidemia, prior coronary stenting, or family history of sudden cardiac arrest and cerebrovascular stroke.
- • Photon-Counting / 640-Slice Coronary CT Angiography (CCTA) + Coronary Artery Calcium (CAC) Score with vulnerable soft-plaque lipid-core quantification.
- • 3.0T/5.0T High-Resolution Intracranial & Cervical Vessel Wall MRI (HR-VWI) + Time-of-Flight MRA to detect unruptured cerebral aneurysms (≥1.5mm) and intracranial atherosclerotic stenosis.
- • 3D Speckle-Tracking Echocardiography & Contrast Carotid Ultrasound measuring intima-media thickness and plaque neovascularization.
- • 72-Hour Waterproof Single-Lead Patch Holter ECG + 24-Hour Central Aortic Blood Pressure Monitoring for occult atrial fibrillation.
- • Advanced Atherogenic Lipid & Thrombosis Panel: Lipoprotein(a) [Lp(a)], ApoB/ApoA1 ratio, oxidized LDL, homocysteine, hs-CRP, NT-proBNP, High-Sensitivity Troponin-I, and Clopidogrel CYP2C19 genotype.
4. Painless AI Pan-Endoscopy, Hepatobiliary & Microbiome Suite
Comprehensive evaluation of the esophagus, stomach, duodenum, small intestine, colon, liver, gallbladder, and pancreas—ideal for patients with GERD, H. pylori history, fatty liver (MASLD/NASH), IBS, or family history of gastrointestinal tumors.
- • Painless Propofol-Sedated Optical Magnifying Gastroscopy & Colonoscopy (80x–135x Optical Zoom + NBI) with real-time AI polyp/dysplasia detection OR Robotic Magnetically Controlled Capsule Endoscopy (zero intubation).
- • MRCP (Magnetic Resonance Cholangiopancreatography) + Upper Abdominal 3.0T MRI for early pancreatic duct and biliary tree evaluation.
- • FibroScan Liver Elastography & MRI-PDFF for non-invasive quantification of hepatic steatosis and fibrosis stage (F0–F4).
- • 13C-Urea Breath Test + H. pylori Antibiotic Resistance Genotyping (Clarithromycin/Levofloxacin resistance genes) for 98% eradication success.
- • Shotgun Metagenomic Gut Microbiome Sequencing + 90-Food IgG/IgE Halal Dietary Sensitivity Profile.
5. Diabetes Reversal, Metabolic Bariatric & Cellular Longevity
Designed for Gulf patients addressing Type 2 diabetes, insulin resistance, obesity, thyroid/adrenal fatigue, or seeking cellular anti-aging and regenerative stem-cell/TCM longevity optimization.
- • 5-Point Oral Glucose, Insulin & C-Peptide Release Curve + Pancreatic Beta-Cell Reserve Quantification & Islet Autoantibodies (GAD, IA-2, ZnT8).
- • Full-Body Dual-Energy X-Ray Absorptiometry (DEXA) Visceral Adipose Tissue (VAT), Sarcopenia Muscle Index, and Bone Mineral Density scan.
- • Comprehensive Diabetic Microvascular Screening: Ultra-Widefield Laser Retinal Angiography (OPTOS), Urinary Albumin-to-Creatinine Ratio, Cystatin-C eGFR, and Quantitative Sudomotor/Nerve Conduction Velocity.
- • Cellular Aging & Immune Competence Assay: Leukocyte Telomere Length, Horvath Epigenetic DNA Methylation Age, NAD+/NADH Ratio, and Flow Cytometry T-Cell Senescence (CD4, CD8, Treg, NK cytotoxicity).
- • 38-Element ICP-MS Heavy Metal & Environmental Endocrine Disruptor Toxicology (Lead, Mercury, Arsenic, Cadmium, Thallium, BPA/Phthalates).
6. Her Royal Elegance All-Female Executive Health & Fertility
Conducted in a strictly private, women-only wing staffed exclusively by female radiologists, female sonographers, female endoscopists, and female Arabic medical interpreters—honoring cultural modesty for women from Saudi Arabia and the GCC.
- • 3.0T Dynamic Contrast-Enhanced Breast MRI + 3D Digital Breast Tomosynthesis + Automated Breast Volume Scanner (ABVS).
- • 3.0T Pelvic MRI & High-Resolution Gynecological Ultrasound for endometriosis, adenomyosis, fibroids, and early ovarian pathology.
- • Reproductive Endocrinology & Ovarian Reserve Profile: AMH, Estradiol, FSH, LH, Progesterone, Prolactin, DHEA-S, Free/Total Testosterone, SHBG, and Autoimmune Thyroid (TPOAb, TgAb, TRAb).
- • Liquid-Based Cytology (TCT) + 28-Subtype Quantitative HPV Genotyping + BRCA1/BRCA2/PALB2 Hereditary Breast/Ovarian Sequencing.
- • Integrative TCM Gynecology & Postpartum/Menopausal Constitutional Balancing Consultation.
Part B: Complete Itemized Diagnostic & Laboratory Examination Schedule (60+ Clinical Tests)
Every examination below can be booked standalone or added to any inpatient/outpatient checkup itinerary. All imaging includes original DICOM files and bilingual English/Arabic specialist reports.
| Code & Examination Name | Technology / Clinical Equipment | Primary Clinical Indication & Diagnostic Value | Prep & Turnaround | Reference Price | Action |
|---|---|---|---|---|---|
| IMG-01: Total-Body 18F-FDG PET-CT | United Imaging uEXPLORER (194cm Axial FOV) / Siemens Biograph Vision Quadra | Whole-body metabolic oncology staging, detection of occult primary tumors (≥2mm), treatment response evaluation, and paraneoplastic fever of unknown origin. Ultra-low radiation dose. | 6h fasting; blood glucose <11 mmol/L • Report in 24h | $1,450 USD | |
| IMG-02: 68Ga-FAPI-04 Fibroblast PET-CT | Gallium-68 Fibroblast Activation Protein Inhibitor Specific Molecular PET | Superior sensitivity over standard FDG for signet-ring gastric cancer, pancreatic ductal adenocarcinoma, cholangiocarcinoma, peritoneal carcinomatosis, and lobular breast cancer. Zero fasting required; high tumor-to-background contrast in brain and liver. | No fasting needed • Report in 24h | $1,650 USD | |
| IMG-03: 68Ga-PSMA-11 / 18F-PSMA PET-CT | Prostate-Specific Membrane Antigen Targeted Molecular PET-CT | Gold-standard localization of primary prostate cancer, biochemical recurrence at ultra-low PSA (≥0.2 ng/mL), and eligibility screening for 177Lu-PSMA-617 radioligand therapy. | Well hydrated; no fasting • Report in 24h | $1,600 USD | |
| IMG-04: 68Ga-DOTATATE Neuroendocrine PET-CT | Somatostatin Receptor (SSTR2) Targeted PET-CT | Precise localization and staging of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), pheochromocytoma, paraganglioma, and meningioma; guides PRRT peptide receptor radionuclide therapy. | Hold long-acting octreotide • Report in 24h | $1,650 USD | |
| IMG-05: Simultaneous Whole-Body PET-MRI (3.0T) | Siemens Biograph mMR / United Imaging uPMR 790 | Combines PET molecular metabolism with 3.0T soft-tissue MRI resolution at 70% lower radiation than PET-CT. Ideal for pediatric oncology, brain gliomas, liver metastases, pelvic malignancies, and executive screening. | 6h fasting; no non-MRI metal • Report in 24–36h | $2,100 USD | |
| IMG-06: 5.0T / 7.0T Ultra-High-Field Brain MRI + MRA + SWI + DTI | uMR Jupiter 5.0T / Siemens Magnetom Terra 7.0T | Sub-millimeter visualization of perforating lenticulostriate arteries, hippocampi subfield atrophy (early Alzheimer's), substantia nigra nigrosome-1 (early Parkinson's), microbleeds, and epileptogenic focal cortical dysplasia invisible on 1.5T/3.0T. | No fasting; 40-min scan • Report in 24h | $880 USD | |
| IMG-07: Dual-Source Photon-Counting Coronary CT Angiography (CCTA) + FFR-CT | Siemens NAEOTOM Alpha Photon-Counting CT / Somatom Force | Eliminates calcium blooming artifacts even in heavily calcified coronary arteries or inside prior stents; calculates non-invasive CT Fractional Flow Reserve (FFR-CT) to determine whether a stenosis requires stenting without invasive catheterization. | 4h fasting; renal eGFR check • Report in 12–24h | $620 USD | |
| IMG-08: 3.0T Cardiac MRI with Late Gadolinium Enhancement (LGE) & T1/T2 Mapping | 3.0T Cardiovascular Magnetic Resonance Suite | Gold standard for assessing myocardial viability prior to CABG bypass surgery, diagnosing hypertrophic/dilated cardiomyopathy, cardiac amyloidosis, myocarditis, and right ventricular arrhythmogenic dysplasia. | 4h fasting; breath-hold coaching • Report in 24h | $750 USD | |
| END-01: Painless Magnifying NBI+BLI Gastroscopy & Colonoscopy | Olympus EVIS X1 / Fujifilm ELUXEO 7000 with 135x Optical Magnification & AI CADe | Performed under target-controlled propofol sedation by an attending anesthesiologist. Identifies microvascular and microsurface pit patterns of early intramucosal gastric, esophageal, and colorectal cancer (<3mm), enabling curative endoscopic submucosal dissection (ESD) without organ removal. | Split-dose PEG bowel prep; 8h fasting • Same-day report (Pathology 48h) | $680 USD | |
| END-02: NaviCam Robotic Magnetically Controlled Capsule Endoscopy | Ankon NaviCam External Robotic Magnetic Guidance System | Swallowable 2.7cm HD camera capsule actively steered in 5 degrees of freedom across the entire stomach and small intestine by an external robotic magnetic arm. Zero sedation, zero intubation, zero discomfort—ideal for elderly or cardiac patients on anticoagulants. | 8h overnight fasting + simethicone water • Report in 24h | $790 USD | |
| END-03: Endoscopic Ultrasound (EUS) with Fine-Needle Biopsy (EUS-FNB) | Olympus EU-ME2 Linear & Radial Echoendoscope | Highest-resolution imaging of the pancreas (<5mm neuroendocrine or cystic IPMN lesions), bile duct, ampulla of Vater, and submucosal GI tumors, with ultrasound-guided core biopsy. | 8h fasting; coagulation panel check • Cytology 24–48h | $920 USD | |
| IMG-09: Gd-EOB-DTPA (Primovist) Hepatobiliary 3.0T MRI + MRCP | 3.0T MRI with Hepatocyte-Specific Contrast & 3D Biliary Reconstruction | Differentiates benign focal nodular hyperplasia (FNH) and hemangiomas from early hepatocellular carcinoma (HCC <1cm) and cholangiocarcinoma; maps exact biliary anatomy before liver surgery. | 4h fasting • Report in 24h | $640 USD | |
| MOL-01: Pan-Cancer ctDNA Methylation Liquid Biopsy (50+ Cancer Types) | Next-Generation Bisulfite Sequencing + Machine Learning Tissue-of-Origin Classifier | Detects cell-free circulating tumor DNA methylation signatures in a single 20mL peripheral blood draw, identifying silent Stage I/II cancers (pancreas, ovary, liver, lung, esophagus, colon, lymphoma) and predicting tissue of origin with >92% accuracy. | 20mL Streck blood draw; no fasting • Report in 5–7 days | $890 USD | |
| MOL-02: Comprehensive 1,021-Gene Solid Tumor NGS + TMB/MSI/HRD/PD-L1 | Illumina NovaSeq 6000 / MGI DNBSEQ-T7 CAP/CLIA Accredited Lab | Matches oncology patients to targeted therapies (EGFR, ALK, ROS1, RET, MET, NTRK, BRAF, HER2, Claudin18.2, FGFR2, BRCA1/2), PARP inhibitors (HRD score), PD-1/PD-L1 immunotherapy (TMB/MSI-H), and CAR-T/ADC clinical trials. | FFPE tissue block or 20mL ctDNA blood • Report in 5–7 days | $1,550 USD | |
| GEN-01: Trio Whole-Genome Sequencing (WGS 30x) for Rare & Pediatric Diseases | Clinical Whole-Genome + Mitochondrial DNA Sequencing (Child + Both Parents) | Essential for Middle Eastern families with consanguineous marriage history investigating undiagnosed pediatric neurological delay, epilepsy, congenital metabolic disorders, primary immunodeficiency, thalassemia variants, or skeletal dysplasia. | EDTA blood from child & parents • Rapid report in 7–10 days | $1,800 USD | |
| URO-01: Multiparametric 3.0T Prostate MRI (PI-RADS v2.1) + MRI-Ultrasound Fusion Biopsy | 3.0T Non-Endorectal Coil mpMRI + Transperineal Robotic Template Fusion | Pinpoints clinically significant prostate cancer foci while avoiding unnecessary blind transrectal biopsies; transperineal approach reduces infection risk to <0.1%. | Enema prep; PSA + PHI blood panel • MRI 24h / Biopsy 48h | $950 USD | |
| IMM-01: Deep Immune Repertoire & Lymphocyte Functional Phenotyping | 18-Color Flow Cytometry + TCR/BCR High-Throughput Sequencing | Quantifies naive vs. exhausted T-cells (PD-1+, TIM-3+), NK cell tumor-killing perforin/granzyme activity, regulatory T-cells, B-cell memory subsets, and cytokine storm risk profile. | Morning blood draw • Report in 48–72h | $580 USD | |
| ORT-01: EOS Full-Body Biplanar Low-Dose 3D Skeletal & Spine Alignment Scan | EOS Nobel-Prize Detector Biplanar Slot-Scanning System | Captures simultaneous weight-bearing AP and lateral full-body skeletal images from head to toe in 15 seconds at 85% less radiation than conventional X-rays; essential for pediatric scoliosis, pelvic tilt, and knee/hip arthroplasty planning. | Standing posture; 15-sec scan • Same-day 3D model | $320 USD |
Major Disease Treatments, Ultra-Complex Surgeries & Heavy-Ion Oncology
When a patient in Riyadh, Dubai, Doha, Kuwait City, or Cairo faces a complex, locally advanced, or recurrent diagnosis—such as a pancreatic tumor encasing the mesenteric vessels, a skull-base chordoma adjacent to the brainstem, an extensive thoracic aortic dissection, or transfusion-dependent beta-thalassemia major—China's national medical centers offer surgical techniques and multidisciplinary protocols that convert "inoperable" cases into long-term survivors.
Radical Pancreaticoduodenectomy (Whipple), ALPPS Liver Resection & Sphincter-Preserving GI Surgery
China's national hepatobiliary and pancreatic centers—including Zhongshan Hospital (Fudan University), Ruijin Hospital, Fudan University Shanghai Cancer Center (FUSCC), Peking Union Medical College Hospital (PUMCH), and The First Affiliated Hospital of Zhejiang University—perform the highest volume of complex liver and pancreatic resections in the world.
1. Locally Advanced Pancreatic Cancer (Borderline Resectable & Vascular Involvement): For tumors invading the portal vein (PV), superior mesenteric vein (SMV), or celiac axis, our pancreatic surgical teams utilize neoadjuvant FOLFIRINOX/nab-paclitaxel conversion therapy followed by Radical Whipple or Distal Pancreatectomy with En-Bloc Celiac Axis Resection (Modified Appleby Procedure) and autologous/allogeneic vascular graft reconstruction. Intraoperative radiotherapy (IORT) and irreversible electroporation (IRE / NanoKnife) are deployed to sterilize retroperitoneal surgical margins, achieving R0 resection rates exceeding 84%.
2. Giant Hepatocellular Carcinoma (HCC) & Hilar Cholangiocarcinoma (Klatskin Tumor): When remnant liver volume is initially insufficient (<30% future liver remnant), surgeons perform ALPPS (Associative Liver Partition and Portal Vein Ligation for Staged Hepatectomy) or portal/hepatic vein embolization with 3D Mixed-Reality holographic navigation, inducing 60%–90% hypertrophy of the healthy liver lobe within 10 to 14 days to allow safe curative resection. For end-stage perihilar tumors invading the inferior vena cava, Ex-Vivo Liver Resection and Autotransplantation (removing the liver to resect the tumor on an ice-bath workbench before re-implanting the healthy remnant) is performed routinely.
3. Ultra-Low Rectal Cancer Anal-Sphincter Preservation (ISR & NOSES): Using Da Vinci Xi robotic intersphincteric resection (ISR) and Natural Orifice Specimen Extraction Surgery (NOSES), over 92% of patients with rectal tumors located just 2–3 cm from the anal verge avoid a permanent colostomy bag—preserving both continence and quality of life.
Tubeless Non-Intubated Uniportal VATS Lung Resection & Complex Tracheal Reconstruction
Pioneered in China at Shanghai Pulmonary Hospital (performing 22,000+ thoracic operations annually—the highest in the world) and the First Affiliated Hospital of Guangzhou Medical University (National Center for Respiratory Medicine), "Tubeless" Uniportal Video-Assisted Thoracoscopic Surgery (VATS) has revolutionized lung cancer treatment.
1. Spontaneous-Breathing "Tubeless" Single-Incision Lung Surgery: Instead of double-lumen endotracheal intubation with mechanical ventilation, neuromuscular paralysis, urinary catheterization, and post-operative chest drainage tubes, patients undergo anatomical pulmonary segmentectomy or lobectomy through a single 2.5 cm intercostal incision under intravenous sedation and thoracic paravertebral nerve block while breathing spontaneously. Patients wake up immediately without throat trauma or ventilator-induced lung injury, walk within 4 hours of surgery, and are frequently discharged within 48 to 72 hours.
2. 3D Bronchovascular Reconstruction for Multiple Ground-Glass Nodules (GGNs): Using pre-operative AI 3D pulmonary artery, vein, and bronchus segmentation, surgeons perform combined sub-segmentectomies (such as RS1+S2a or LS1+2c) that remove multiple early lung adenocarcinomas while preserving over 88% of pulmonary ventilatory function—critical for elderly patients or those with COPD/emphysema.
3. Sleeve Lobectomy, Carinal Resection & Mediastinal Tumors: For central lung tumors invading the main bronchus or pulmonary artery, double-sleeve broncho-angioplastic reconstruction avoids total pneumonectomy. For giant thymomas with myasthenia gravis or superior vena cava invasion, robotic and hybrid vascular prosthetic replacement is performed with full neurological ICU support.
Proton & Carbon Heavy-Ion Radiotherapy (SPHIC) & Boron Neutron Capture Therapy (BNCT)
The Shanghai Proton and Heavy Ion Center (SPHIC), affiliated with Fudan University Cancer Hospital, is one of only a handful of medical facilities worldwide equipped with both Proton and Carbon Heavy-Ion (12C6+) synchrotron particle beams under one roof, having treated over 7,500 international and domestic patients with remarkable local tumor control.
1. The Physical & Radiobiological Advantage of Carbon Heavy Ions: Unlike conventional X-ray photons (IMRT/SBRT) that deposit radiation along their entire entry and exit path, accelerated Carbon-12 ions travel through healthy tissue with minimal energy release and deposit their maximum destructive energy at a precisely calculated depth known as the Bragg Peak, followed by a near-zero exit dose. Furthermore, Carbon Heavy Ions possess a Relative Biological Effectiveness (RBE) 2.5 to 3.5 times higher than protons or X-rays, causing direct double-strand DNA breaks that eradicate hypoxic, radio-resistant tumors (such as chordomas, sarcomas, adenoid cystic carcinomas, and pancreatic adenocarcinoma).
2. Core Clinical Indications & 5-Year Control Rates at SPHIC:
• Skull Base & Sacral Chordoma / Chondrosarcoma: 5-year local control >86% while sparing the brainstem, optic chiasm, and sacral nerves.
• Locally Advanced Nasopharyngeal Carcinoma & Recurrent Head/Neck Cancer: Salvage carbon-ion re-irradiation achieves 2-year overall survival >82% with minimal carotid blowout risk.
• Unresectable Hepatocellular Carcinoma (HCC) & Pancreatic Cancer: Respiratory-gated pencil-beam scanning completes treatment in 10 to 15 outpatient sessions without anesthesia or incision.
• Localized & High-Risk Prostate Cancer: 5-year biochemical progression-free survival >95% with preserved urinary and sexual function.
3. Boron Neutron Capture Therapy (BNCT) in Boao Lecheng: For recurrent glioblastoma and malignant melanoma, patients receive an intravenous boron-10 phenylalanine (BPA) infusion that selectively accumulates inside tumor cells, followed by a single 30-to-60-minute epithermal neutron irradiation session that destroys cancer cells at the cellular scale (<10 microns).
Total Aortic Arch Replacement (Sun's Procedure), TAVR/TAVI, MitraClip & Artificial Heart (LVAD)
Led by Fuwai Hospital (National Center for Cardiovascular Diseases, Beijing—the world's largest heart hospital performing 18,000+ cardiac surgeries and 45,000+ interventional procedures annually), Beijing Anzhen Hospital, Zhongshan Hospital, and Guangdong Cardiovascular Institute.
1. Acute & Chronic Stanford Type A Aortic Dissection ("Sun's Procedure"): Invented in Beijing and adopted globally as the gold standard for complex aortic arch pathology, Total Aortic Arch Replacement using a 4-Branched Vascular Graft combined with Stented Frozen Elephant Trunk Implantation in the descending thoracic aorta reduces perioperative mortality of catastrophic aortic dissection to under 4.5%—less than one-fourth the global average. For high-risk thoracoabdominal aneurysms, custom 3D-fenestrated and branched endovascular aortic repair (FEVAR/BEVAR) is performed without open thoracotomy.
2. Transcatheter Structural Heart Interventions (TAVR, MitraClip, DragonFly & LuX-Valve): Octogenarian and high-surgical-risk patients with severe aortic stenosis, bicuspid aortic valve, mitral regurgitation, or torrential tricuspid regurgitation undergo beating-heart transcatheter valve replacement or repair via femoral access, walking out of the hospital within 3 to 4 days.
3. Total Arterial Off-Pump CABG & Third-Generation Maglev Artificial Heart (LVAD): For diffusediabetic multi-vessel coronary disease (highly prevalent in the GCC) and ischemic cardiomyopathy with Ejection Fraction <20%, surgeons perform beating-heart bilateral internal mammary artery (BIMA) bypass, hybrid coronary revascularization, or implant the ultra-compact CorHeart 6 / CH-VAD magnetically levitated Left Ventricular Assist Device (weighing just 90 grams) as destination therapy.
Skull Base Microsurgery, Awake Glioma Craniotomy, Moyamoya Bypass & DBS / MRgFUS
Anchored by Beijing Tiantan Hospital (National Center for Neurological Disorders, operating 15,000+ brain tumors and cerebrovascular cases annually) and Huashan Hospital (Fudan University, Shanghai—hosting the largest neurosurgical institute in Asia).
1. Skull Base, Brainstem Cavernoma & Acoustic Neuroma Microsurgery: Tumors located in the petroclival region, cavernous sinus, foramen magnum, or intrinsic brainstem (pons/medulla) are resected under 4K 3D exoscopes with continuous 24-channel intraoperative neurophysiological cranial nerve monitoring—achieving facial and cochlear nerve anatomical preservation in over 93% of acoustic neuroma cases.
2. Awake Craniotomy with Intraoperative 3.0T MRI & Arabic Language Mapping: For gliomas located inside Broca's speech area or the primary motor cortex, our anesthesiology and neuropsychology teams conduct awake brain mapping with a native Arabic interpreter inside the operating theater, verifying speech and motor pathways in real time while intraoperative 3.0T MRI confirms supramarginal tumor resection.
3. Giant Intracranial Aneurysm Bypass & Moyamoya Disease Revascularization: High-flow EC-IC radial artery/saphenous vein bypass and combined direct/indirect STA-MCA revascularization restore cerebral perfusion with <1.5% stroke morbidity.
4. Deep Brain Stimulation (DBS) & Incisionless MRgFUS Focused Ultrasound: Rechargeable 3.0T-MRI-compatible directional DBS systems (Pins / SceneRay / Medtronic) with remote 5G tele-programming allow Middle Eastern Parkinson's, essential tremor, and dystonia patients to have their neurostimulator fine-tuned online after returning home to Riyadh, Dubai, or Doha.
Curative Haploidentical Stem Cell Transplant ("Beijing Protocol") for Thalassemia, Sickle Cell & Leukemia
One of the most impactful medical breakthroughs for Middle Eastern families is the "Beijing Protocol" for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (Haplo-HSCT), developed by Academician Huang Xiaojun at Peking University People's Hospital (Institute of Hematology) and practiced across Ruijin Hospital, Blood Diseases Hospital (CAMS Tianjin), and Southern Medical University Nanfang Hospital.
1. Solving the HLA Donor Shortage ("Everyone Has a Donor"): Historically, curing Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Severe Aplastic Anemia, or Transfusion-Dependent Beta-Thalassemia Major required a 10/10 fully matched sibling or unrelated registry donor—which fewer than 30% of patients possess. Using the G-CSF + ATG / low-dose PT-Cy "Beijing Protocol," any biological parent, child, or half-matched (5/10 HLA) sibling can serve immediately as a stem cell donor, achieving engraftment and leukemia-free survival rates identical to fully matched sibling transplants.
2. 97%+ Thalassemia-Free Survival for GCC & Mediterranean Children: Beta-Thalassemia Major and Sickle Cell Disease are highly prevalent across Saudi Arabia, UAE, Oman, Bahrain, Kuwait, Iraq, Jordan, and Egypt. Our pediatric hematology centers in Nanfang Hospital (Guangzhou), Shenzhen Children's Hospital, and Beijing Children's Hospital have cured over 3,500 children with Beta-Thalassemia Major using Haplo-HSCT or novel Autologous BCL11A Gene-Edited Stem Cell Therapy (RM-001 / CS-101)—permanently eliminating lifelong blood transfusions and iron chelation.
3. Sequential CAR-T Bridge to Allogeneic HSCT: For patients with relapsed/refractory B-ALL or T-ALL who fail chemotherapy, we administer CAR-T therapy first to achieve Minimal Residual Disease (MRD)-negative complete remission within 21 days, followed immediately by consolidative Haploidentical HSCT inside Class-100 sterile laminar-flow cabins, raising 3-year disease-free survival from <15% to over 76%.
Living-Related Pediatric & Adult Liver Care, Biliary Atresia & Complex Renal Reconstruction
Renji Hospital (Shanghai Jiao Tong University School of Medicine) is the world's single largest pediatric and adult living-donor liver transplant center (performing 800+ liver transplants per year with over 3,500 pediatric living-donor cases completed), alongside FAHZU (Hangzhou) and Beijing Friendship Hospital.
1. Legal & Ethical Living-Related Organ Donation Framework for International Families: In strict compliance with the Declaration of Istanbul and Chinese Ministry of Health regulations, international patients may undergo living-related liver or kidney transplantation in China when accompanied by a verified biological relative (parent, adult child, sibling, or spouse) with notarized kinship documentation authenticated by the patient's embassy and hospital ethics committee.
2. Pediatric Biliary Atresia & Inherited Metabolic Liver Diseases: For infants weighing as little as 4.5 kg suffering from biliary atresia (failed Kasai procedure), Crigler-Najjar syndrome, urea cycle defects, Maple Syrup Urine Disease, or progressive familial intrahepatic cholestasis (PFIC), surgeons harvest the left lateral segment (20% of the liver) from a parent using 100% Laparoscopic or Robotic Donor Hepatectomy. The parent recovers within 5 days with a bikini-line scar, while 1-year and 5-year infant survival rates at Renji Hospital exceed 96% and 93% respectively.
3. Adult Dual-Graft, ABO-Incompatible & Portal Vein Thrombosis Reconstruction: Advanced microsurgical hepatic artery anastomosis under 12x operating microscopes and desensitization protocols (Rituximab + DFPP plasmapheresis) allow successful living-related transplantation even across incompatible blood types (ABO-i).
3D-Printed Custom Titanium Bone Tumor Prostheses, Severe Scoliosis Correction & Diabetic Limb Salvage
Led by Peking University Third Hospital (PUTH), Beijing Jishuitan Hospital (National Center for Orthopedics), PKU People's Hospital Musculoskeletal Tumor Center, and Shanghai Sixth People's Hospital (world pioneer in limb replantation and microsurgical reconstruction).
1. Patient-Specific 3D-Printed Porous Titanium Pelvic & Vertebral Reconstruction: For osteosarcoma, Ewing sarcoma, giant cell tumor of bone, or spinal metastases, engineers design a custom electron-beam-melted (EBM) 3D-printed trabecular titanium prosthesis matched to the patient's CT scan within 5 days. Following en-bloc tumor resection (including multi-level total en-bloc spondylectomy or hemipelvectomy), the 3D-printed implant restores immediate weight-bearing stability and osseointegration—avoiding hindquarter amputation in over 90% of pelvic tumor patients.
2. Extreme Scoliosis & Kyphosis Correction (Cobb Angle >100°): Using halo-gravity traction followed by TINAVI robotic-navigated vertebral column resection (VCR) and continuous multimodal spinal cord monitoring, severe congenital and neuromuscular spinal deformities are corrected safely.
3. Diabetic Foot Limb-Salvage & Transverse Tibial Bone Transport (Ilizarov): For Gulf patients facing below-knee amputation due to severe diabetic foot gangrene and ischemic microangiopathy, Shanghai Sixth People's Hospital and Guang'anmen Hospital combine endovascular below-the-knee angioplasty, Transverse Tibial Cortex Transport (which stimulates massive capillary angiogenesis in the foot), free-flap microsurgery, and herbal wound regeneration—achieving a 91% limb-salvage rate.
Molecular Subtype-Guided Breast Conservation, Immediate DIEP Reconstruction & Lymphedema Cure
At Fudan University Shanghai Cancer Center (FUSCC—treating 8,500+ new breast cancer cases annually with a 5-year overall survival of 93.6%), Professor Shao Zhimin's team pioneered the "Fudan Classification" of Triple-Negative Breast Cancer (TNBC), transforming treatment outcomes through precision subtyping.
1. Endoscopic/Robotic Nipple-Sparing Mastectomy & Autologous DIEP Flap: Through a single concealed axillary incision with zero visible scars on the breast mound, surgeons perform nipple-sparing mastectomy with immediate autologous Deep Inferior Epigastric Perforator (DIEP) free-flap reconstruction (using excess lower abdominal tissue) or pre-pectoral implant reconstruction.
2. Supermicrosurgical Lymphaticovenular Anastomosis (LVA) for Arm/Leg Lymphedema: Using 40x ultra-high-magnification microscopes and indocyanine green (ICG) near-infrared lymphangiography, plastic microsurgeons anastomose 0.3 mm lymphatic vessels directly to subdermal venules under local or light anesthesia, draining chronic post-mastectomy arm swelling rapidly with immediate circumference reduction.
Robotic Nerve-Sparing Radical Prostatectomy, Zero-Ischemia Kidney Salvage & Neobladder
Performed at Peking University First Hospital (Institute of Urology), Changhai Hospital, FUSCC, and Sun Yat-sen University Cancer Center using Da Vinci Xi and Single-Port (SP) robotic platforms.
1. Retzius-Sparing & NeuroSAFE Robotic Radical Prostatectomy: By preserving the space of Retzius, puboprostatic ligaments, and neurovascular bundles verified by intraoperative frozen-section pathology (NeuroSAFE), over 91% of patients achieve immediate urinary continence upon catheter removal on Day 7, with high erectile function preservation.
2. Zero-Ischemia Robotic Partial Nephrectomy for Complex Renal Tumors (RENAL Score ≥10): Using 3D holographic renal artery branch clamping or off-clamp tumor enucleation, even deep hilar or solitary-kidney tumors up to 7 cm are removed while saving the kidney and preventing lifelong hemodialysis.
3. Intracorporeal Robotic Radical Cystectomy + Orthotopic Studer Ileal Neobladder: For muscle-invasive bladder cancer, a new functional bladder is constructed entirely robotically from a detubularized segment of ileum and connected to the native urethra, allowing natural voiding without an external urostomy bag.
High-Risk Neuroblastoma (GD2 + Surgery), Eye-Sparing Retinoblastoma & Complex Congenital Heart Repair
Coordinated through Beijing Children's Hospital (National Center for Children's Health), Shanghai Children's Medical Center (SCMC), Fudan Children's Hospital, and Xinhua Hospital.
1. Eye-Salvage Ophthalmic Artery Chemosurgery (IAC) for Pediatric Retinoblastoma: At Xinhua Hospital and Beijing Tongren Hospital, microcatheter super-selective infusion of melphalan/topotecan directly into the infant's 0.4 mm ophthalmic artery combined with intravitreal therapy achieves a >90% globe-salvage rate in Group D/E retinoblastoma, sparing children from eye enucleation.
2. Multimodal High-Risk Neuroblastoma & Wilms Tumor Protocol: Combines vascular-skeletonization retroperitoneal tumor resection, tandem autologous stem cell rescue, proton radiotherapy, and anti-GD2 monoclonal antibody (Dinutuximab beta / Naxitamab) immunotherapy.
3. Neonatal Complex Congenital Heart Defect Surgery: Arterial switch for transposition of the great arteries (TGA), Norwood/Fontan staged palliation, Nikaidoh procedure, and Ebstein anomaly cone reconstruction with >97.8% survival.
Robotic Bariatric Surgery (LSG / OAGB / RYGB) & Autologous Stem-Cell Islet Regeneration for Diabetes
Addressing the high prevalence of Type 2 Diabetes and metabolic syndrome across the Arabian Gulf, our centers at Ruijin Hospital (National Metabolic Management Center), Shanghai Changzheng Hospital, and Peking University Health Science Center offer both surgical and cellular solutions.
1. Single-Port / Robotic Sleeve Gastrectomy (LSG) & One-Anastomosis Gastric Bypass (OAGB): Performed with enhanced recovery after surgery (ERAS) protocols, achieving 70%–85% excess weight loss and 82% complete remission of Type 2 Diabetes (HbA1c <6.0% off insulin) within 6 months, with a 3-to-4-day hospital stay.
2. Groundbreaking Chemical Induced Pluripotent Stem-Cell (CiPSC) & Endoderm Stem-Cell Islet Transplantation: Landmark clinical trials published in Cell and Nature Medicine (2024–2026) by Chinese teams at Shanghai Changzheng Hospital (Naval Medical University) and Peking University / Tianjin First Central Hospital achieved the world's first functional cures of Type 1 and insulin-dependent Type 2 diabetes using patient-derived reprogrammed stem-cell islets infused into the portal vein or abdominal rectus sheath. Eligible international patients are evaluated for clinical protocol enrollment and islet function restoration.
CAR-T Cell Therapy, Dual-Target Allogeneic CAR-T, Solid-Tumor Claudin18.2/GPC3 & Autoimmune Reset Protocols
China hosts the world's largest clinical ecosystem for Chimeric Antigen Receptor T-Cell (CAR-T) therapy, with over 650 registered clinical programs and six NMPA-approved commercial CAR-T products deployed at premier hematology and oncology centers including Ruijin Hospital (Shanghai), Peking University People's Hospital (Beijing), The First Affiliated Hospital of Zhejiang University (Hangzhou), Union Hospital (Wuhan), and Boao Super Hospital (Hainan).
For patients from Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, and Egypt facing relapsed or refractory B-Cell Lymphoma (DLBCL, MCL, FL), Multiple Myeloma (MM), B-Cell or T-Cell Acute Lymphoblastic Leukemia (ALL), Gastric/Pancreatic Cancer, Hepatocellular Carcinoma, Glioblastoma, or severe refractory Systemic Lupus Erythematosus (SLE), China offers three decisive advantages over North America and Western Europe: (1) 65%–80% lower treatment cost ($45,000–$165,000 USD vs. $475,000–$680,000 USD in the US); (2) Rapid 12-to-18-day GMP vein-to-vein cell manufacturing (including 3-day "FasTCAR" next-day manufacturing platforms); and (3) Access to next-generation Dual-Target (CD19/CD22, BCMA/GPRC5D, CD7) and Solid-Tumor CAR-T protocols unavailable elsewhere.
Every autologous and allogeneic CAR-T batch undergoes automated closed-system lentiviral/retroviral transduction, digital droplet PCR (ddPCR) vector copy number verification, sterility/endotoxin release testing, and real-time flow-cytometric viability certification before infusion.
Commercial NMPA-Approved & Investigator-Initiated (IIT) CAR-T / Cellular Therapies in China
Complete molecular target, indication, clinical response rate (ORR / CR), manufacturing turnaround, and transparent package pricing.
| CAR-T Product / Protocol Name | Molecular Target | Approved / Clinical Indications | Published Efficacy (ORR / CR) | China Total Cost | US / EU Equivalent |
|---|---|---|---|---|---|
| Carteyva® (Relmacabtagene autoleucel / 瑞基奥仑赛) | CD19 (4-1BB co-stimulatory) | Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), and Refractory SLE Lupus | ORR 77.6% • CR 53.5% (Low severe CRS <5%) | $162,000 USD | $475,000 – $550,000 |
| YiKaiDa® (Axicabtagene ciloleucel / 阿基仑赛) | CD19 (CD28 co-stimulatory) | 2nd-Line & Relapsed/Refractory Large B-Cell Lymphoma (LBCL), Primary Mediastinal B-Cell Lymphoma (PMBCL) | ORR 83.0% • CR 58.0% (Real-world China data) | $165,000 USD | $495,000 – $620,000 |
| Fucaso® (Equecabtagene autoleucel / 伊基奥仑赛) | Fully Human BCMA | Relapsed/Refractory Multiple Myeloma (RRMM), Plasma Cell Leukemia, and Neuromyelitis Optica / Myasthenia Gravis | ORR 96.0% • Stringent CR/CR 74.3% (FUMANBA-1) | $158,000 USD | $520,000 – $650,000 |
| Carvykti® (Ciltacabtagene autoleucel / 西达基奥仑赛) | Dual-Epitope VHH BCMA | Relapsed/Refractory Multiple Myeloma (originated by Legend Biotech China; global gold standard) | ORR 97.9% • Stringent CR 82.5% (CARTITUDE) | $165,000 USD | $555,000 – $680,000 |
| YuanRuiDa® (Inaticabtagene autoleucel / 纳基奥仑赛) | HI19a Novel CD19 scFv | Adult & Adolescent Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL) | ORR 82.1% • MRD-Negative CR 93% of responders | $140,000 USD | $475,000 – $590,000 |
| SaiKaiZe® (Zevorcabtagene autoleucel / 泽沃基奥仑赛) | Fully Human BCMA | Relapsed/Refractory Multiple Myeloma with Extramedullary Plasmacytoma or Renal Impairment | ORR 92.2% • CR/sCR 71.6% (LUMMICAR) | $155,000 USD | $510,000+ |
| Dual-Target Tandem CD19/CD22 or CD19/CD20 CAR-T (Hospital IIT / Compassionate) | CD19 + CD22 / CD20 Bispecific | Pediatric & Adult B-ALL or B-NHL including patients who relapsed with CD19-negative antigen escape after prior therapy | MRD-Negative CR 90%–96% in B-ALL | $48,000 – $75,000 USD | Limited availability |
| Donor-Derived / Universal Off-the-Shelf CD7 CAR-T ("Naturally Selected") | CD7 (Fratricide-Resistant) | Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) & T-Cell Lymphoblastic Lymphoma (T-LBL) | CR 85%–90% at Day 28 (Bridge to Haplo-HSCT) | $55,000 – $82,000 USD | Rarely available |
| Dual BCMA + GPRC5D or CS1 CAR-T for Ultra-Refractory Myeloma | BCMA + GPRC5D | Multiple Myeloma relapsing after prior BCMA CAR-T or bispecific antibodies (Teclistamab) | ORR 86% in BCMA-exposed myeloma | $58,000 – $85,000 USD | Not commercially available |
| Solid-Tumor Claudin18.2 (CT041 / Satri-cel) & GPC3 CAR-T | Claudin18.2 / Glypican-3 (GPC3) | Advanced Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (Claudin18.2+), and Hepatocellular Carcinoma (GPC3+) | Gastric ORR 48.8% • Disease Control Rate (DCR) 73.2% | $62,000 – $95,000 USD | Pioneered in China |
| Autoimmune Deep B-Cell Reset CAR-T (CD19 or BCMA/CD19 Dual) | CD19 + BCMA (Autoantibody Reset) | Refractory Systemic Lupus Erythematosus (SLE with Lupus Nephritis), Systemic Sclerosis, Idiopathic Inflammatory Myopathy, Sjogren's, Myasthenia Gravis | >85% drug-free clinical remission (DORIS/LLDAS) | $52,000 – $78,000 USD | $450,000+ (Compassionate) |
| Autologous TILs (Tumor-Infiltrating Lymphocytes) & TCR-T / Allogeneic NK Cells | Polyclonal Neoantigens / NY-ESO-1 / Cord NK | Metastatic Melanoma, Cervical Cancer, Non-Small Cell Lung Cancer (NSCLC), Synovial Sarcoma, and Post-Chemo Immune Consolidation | Durable tumor shrinkage in PD-1 refractory solid tumors | $28,000 – $68,000 USD | $515,000 USD (Amtagvi) |
The 28-Day CAR-T Clinical Pathway for Middle Eastern Patients
Patient sends bone marrow biopsy reports, immunohistochemistry (IHC)/flow cytometry results, and PET-CT scans via WhatsApp. Upon arrival in Shanghai, Beijing, or Hangzhou, we perform quantitative target antigen expression assays (CD19, CD22, BCMA, CD7, or Claudin18.2 density), viral serology, echocardiography, and organ function clearance within 48 hours.
Using a gentle Terumo Spectra Optia apheresis system over 3 to 4 hours in a private VIP suite, T-lymphocytes are collected from a peripheral vein or central catheter. The patient experiences no pain and returns to their hotel or VIP suite the same afternoon.
Inside our ISO Class-5 GMP laboratory, T-cells are transduced with the CAR lentiviral vector and expanded to hundreds of millions of tumor-specific killer T-cells. If the patient has rapidly proliferating bulky disease, tailored low-toxicity bridging therapy (such as Polatuzumab, Zanubrutinib, Venetoclax, or localized low-dose radiotherapy) keeps tumor burden controlled during manufacturing.
A 3-day conditioning regimen of Fludarabine (25–30 mg/m²) and Cyclophosphamide (250–500 mg/m²) creates optimal immunological space and homeostatic cytokines (IL-7, IL-15). On Day 0, the engineered CAR-T cells are infused intravenously over 15 to 30 minutes under continuous bedside monitoring.
Daily flow cytometry tracks CAR-T expansion peaks (typically Day +7 to +12) alongside serum IL-6, IFN-gamma, ferritin, and CRP. Our centers maintain immediate bedside stocks of Tocilizumab, Siltuximab, Anakinra, and Ruxolitinib, reducing Grade ≥3 Cytokine Release Syndrome (CRS) or neurotoxicity (ICANS) to <4%. On Day +28, bone marrow multiparameter flow cytometry (10⁻⁵ sensitivity) and PET-CT confirm Minimal Residual Disease (MRD) negativity before the patient flies home.
CAR-T Architecture & Cytokine Safety Matrix
Our fourth-generation and dual-targeting CAR constructs incorporate humanized scFv domains (preventing anti-mouse human antibodies and enabling re-infusion if needed) plus inducible safety switches.
Unlike Rituximab (which only depletes circulating CD20+ B-cells while sparing tissue-resident plasmablasts), Dual CD19/BCMA CAR-T therapy penetrates deep into lymph nodes and bone marrow, wiping out autoreactive B-cell clones and resetting the immune system to a healthy naive state—allowing over 85% of severe Lupus Nephritis and Systemic Sclerosis patients to discontinue all corticosteroids and immunosuppressants permanently.
Our partner hospitals operate over 380 multi-arm laparoscopic, single-port, orthopedic, spine, and stereotactic neurosurgical robotic systems, with individual chief surgeons having personally completed 2,500 to 6,000+ robotic operations.
Next-Generation Surgical Robotics: Da Vinci Xi/SP, Toumai 5G, Mako, TINAVI TiRobot & Remebot
Robotic-assisted surgery transforms major oncology, urological, thoracic, cardiac, orthopedic, and neurosurgical operations into minimally invasive procedures with 10x–15x magnified 3D-HD vision, 540-degree EndoWrist articulation (exceeding the range of motion of the human wrist in tight pelvic and mediastinal spaces), physiological tremor filtration, and sub-millimeter bone/brain navigation.
For Middle Eastern patients, especially those with diabetes, obesity, or cardiovascular comorbidities that elevate wound-healing and bleeding risks, robotic surgery reduces blood loss by 75% to 90% (virtually eliminating blood transfusions), cuts post-operative pain and infection rates by over 70%, and shortens hospital stays by half.
1. Da Vinci Xi (4-Arm) & Da Vinci SP (Single-Port) Systems
Deployed across Ruijin, Zhongshan, PUMCH, 301 Hospital, and Boao Lecheng. The Da Vinci SP (Single-Port) inserts three multi-jointed wristed instruments and a fully articulating 3D-HD camera through a single 2.5 cm cannula (or transorally/transanally), enabling scarless radical prostatectomy, partial nephrectomy, thymectomy, and transoral robotic oropharyngeal tumor resection.
2. Toumai® (MicroPort) & KangDuo® 4-Arm Endoscopic Robots
China's NMPA- and CE-certified flagship four-arm laparoscopic surgical robots feature force-feedback sensing, ICG fluorescence lymph node navigation, and dual-console teaching capability. Offering identical clinical outcomes to imported platforms while reducing disposable robotic instrument surcharges by $4,000 to $6,000 USD per procedure.
3. TINAVI TiRobot® (Tianji) Orthopedic & Spine Navigation Robot
Co-developed with Beijing Jishuitan Hospital, TiRobot is the world's only orthopedic surgical robot capable of operating across the entire spine (upper cervical C1/C2 odontoid to sacrum), pelvis/acetabulum, and all four limbs. Real-time 3D C-arm registration achieves <0.6 mm pedicle screw placement accuracy through percutaneous 1 cm keyhole incisions, preventing spinal cord or vertebral artery injury.
4. Stryker Mako SmartRobotics™ & Kunlun Joint Replacement Robots
Pre-operative CT-based 3D bone modeling combined with AccuStop™ haptic boundary technology allows surgeons to resurface osteoarthritic knee or hip joints within 0.5 mm and 0.5° of kinematic alignment, preserving healthy bone stock and cruciate ligaments. Patients stand and walk with a physical therapist on the same day of surgery.
5. Remebot® & Sinovation® Frameless Neurosurgical Robots
Eliminates painful metal stereotactic head frames. Using optical 3D facial/scalp laser registration fused with 3.0T/5.0T MRI and MRA angiograms, the 6-axis robotic arm guides deep brainstem tumor biopsies, Stereo-EEG epilepsy electrode arrays (12–18 electrodes placed in 45 minutes), Laser Interstitial Thermal Therapy (LITT) ablation, and DBS lead implantation with 0.39 mm trajectory accuracy.
6. Ion™ / Monarch™ Bronchoscopic & CorPath® Endovascular Robots
Shape-sensing robotic bronchoscopy navigates through 8th-generation peripheral airways to biopsy and microwave-ablate (MWA) or cryo-ablate pulmonary nodules through the mouth with zero chest incisions—ideal for frail patients or multifocal lung nodules. Endovascular robots perform sub-millimeter coronary and neurovascular stenting.
End-to-End Cross-Border Medical Referral, 48-Hour Tele-MDT & International Air Ambulance Evacuation
Traveling abroad for critical medical care should never burden a patient or their family with logistical uncertainty. Our dedicated Sino-Gulf Cross-Border Referral Command Center operates 24/7 across Riyadh, Jeddah, Dubai, Abu Dhabi, Doha, Kuwait City, Muscat, Manama, Amman, Cairo, and our Chinese hospital hubs in Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, and Hainan Boao.
From the moment you message our medical triage desk on WhatsApp (+86 180 7951 9899), a senior bilingual physician case manager takes full ownership of your medical dossier translation, professor-level video consultation, official hospital admission letter, aviation medical clearance (MEDIF), airport tarmac ambulance reception, and inpatient care.
Direct bed-to-bed ICU air ambulance jets (Gulfstream G550 / Bombardier Challenger 605) and commercial airline stretcher modules with full diplomatic customs clearance on the airport tarmac in Beijing, Shanghai, and Guangzhou.
Commercial First / Business Class with Medical Escort
Ideal for stable oncology, diagnostic, orthopedic, or pre-surgical patients flying on direct 6.5–8.5 hour routes via Emirates, Etihad, Saudia, Qatar Airways, Gulf Air, Oman Air, EgyptAir, Air China, China Southern, or China Eastern.
- • Complete IATA MEDIF airline medical clearance & FAA-approved portable oxygen concentrator (Inogen/Philips) coordination.
- • Optional ACLS-certified flight physician or ICU nurse accompanying the patient door-to-door from their home in the Gulf to the Chinese hospital ward.
- • VIP airport wheelchair/electric buggy meet-and-greet at the aircraft door and private Mercedes V-Class / Alphard medical transfer.
Commercial Airline Cabin Stretcher Module
For patients who must remain supine (such as spinal metastasis, post-stroke hemiplegia, hip/pelvic fracture, or severe debility) but do not require invasive mechanical ventilation, a certified privacy-curtained airline stretcher is installed across 6–9 seats in the commercial cabin.
- • Saves 65%–75% compared to a private air ambulance jet while providing continuous high-flow cabin oxygen (up to 6–8 L/min), multiparameter telemetry, and intravenous infusion pumps.
- • Accompanied by 1 flight physician + 1 critical care nurse + 2 family members in adjacent Business/Economy seats.
- • High-lift ambulance transfer directly at the aircraft side in Riyadh/Dubai/Doha and Beijing/Shanghai/Guangzhou.
Dedicated Flying ICU Air Ambulance Jet (Bed-to-Bed)
For critically ill patients in ICU across the Middle East requiring urgent transfer for life-saving surgery, liver/stem-cell rescue, aortic dissection repair, or CAR-T salvage, we dispatch a dedicated long-range ICU medical jet within 12 to 24 hours.
- • Equipped with Hamilton-T1 ICU transport ventilator, Maquet Cardiohelp mobile ECMO, IABP, point-of-care i-STAT blood gas analyzer, defibrillator, and 8-channel syringe pumps.
- • Sea-Level Cabin Pressurization capability for patients with brain edema, pneumothorax, or recent craniotomy.
- • Tarmac-to-ICU green channel: Chinese customs and border officers board the ambulance on the airport apron for 10-minute clearance.
The 8-Stage Sino-Gulf Cross-Border Referral Protocol
Send medical reports, lab panels, pathology, and DICOM CT/MRI/PET scans via WhatsApp or secure cloud link. Our medical translators prepare a structured bilingual clinical summary.
45-minute Zoom/Voov video conference with the Chief of Surgery/Oncology/Hematology at our partner Chinese hospital, attended by the patient, family, and Arabic medical interpreter.
Receive a formal written Hospital Treatment Proposal detailing diagnostic steps, surgical/CAR-T protocol, expected length of stay, and itemized transparent cost estimate (or Insurance GOP request).
GCC citizens (UAE, Qatar, KSA, Oman, Bahrain, Kuwait) utilize 30-day visa-free or express medical entry; for other MENA nationalities, we issue official Hospital & Government Visa Invitation Letters within 24 hours.
Flight booking, medical escort or air ambulance dispatch, and VIP airport tarmac reception directly to the reserved International Medical Wing (IMS) suite.
Zero emergency room queuing. Immediate bed admission, 24/7 bedside Arabic medical interpretation, Halal meals delivered three times daily, and daily family briefings.
Comprehensive English & Arabic discharge dossier, DICOM USB/Cloud archive, fit-to-fly certificate, and customs clearance documentation for 3–6 months of take-home targeted/TCM medications.
Scheduled 1-, 3-, 6-, and 12-month remote video follow-ups between the Chinese professor and the patient's local physician in Riyadh, Dubai, Doha, Kuwait, Muscat, or Cairo.
Partnered with China Academy of Chinese Medical Sciences (Guang'anmen & Xiyuan Hospitals, Beijing), Longhua & Shuguang Hospitals (Shanghai), and First Teaching Hospital of Tianjin University of TCM.
Traditional Chinese Medicine (TCM), Neurological Stroke Rehabilitation & Halal Herbal Oncology Support
Across the Arabian Gulf, patients and royal families increasingly seek China's nationally accredited Integrative Medicine (Combining Modern Western Medicine with Evidence-Based Traditional Chinese Medicine)—not as an unverified alternative, but as a clinically validated synergistic therapy that accelerates post-stroke brain plasticity, relieves chronic spine and joint pain without surgery, restores kidney and metabolic function, and protects bone marrow and immunity during cancer treatment.
Crucially, for our Muslim patients from Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, and Egypt, our hospital pharmacies operate a strict Halal Botanical Purity Protocol: every herbal prescription is 100% plant- and mineral-derived (zero porcine gelatin capsules, zero alcohol extracts, and zero non-Halal animal ingredients), tested by ICP-MS for zero heavy-metal or pesticide residues, and packaged in vacuum-sealed GMP instant-dissolving herbal granules with bilingual English/Arabic customs certificates for effortless travel home.
"Xing Nao Kai Qiao" Brain-Awakening Acupuncture + Robotic Exoskeleton Rehab
Developed by Academician Shi Xuemin at the First Teaching Hospital of Tianjin University of TCM and practiced across our Beijing and Shanghai neuro-rehab centers. Combines specialized scalp and meridian electro-acupuncture with Brain-Computer Interface (BCI) upper/lower-limb rehabilitation robots, Transcranial Magnetic Stimulation (rTMS), Hyperbaric Oxygen Therapy (HBOT), and speech/swallowing therapy. Markedly improves hemiplegia, aphasia, dysphagia, spinal cord injury paraplegia, and pediatric cerebral palsy motor scores within a 3-to-6-week intensive inpatient stay.
Oncology Detoxification, Bone Marrow Protection & Anti-Recurrence TCM
Led by Guang'anmen Hospital (Beijing) and Longhua Hospital (Shanghai)—China's National TCM Oncology Centers collaborating with the US National Cancer Institute (NCI). Customized botanical formulas (such as Astragalus, Ganoderma lucidum spore oil, Ginsenoside Rg3, and Scutellaria) alongside oncology acupuncture prevent chemotherapy-induced leukopenia/thrombocytopenia, resolve taxane/oxaliplatin peripheral numbness, heal radiation mucositis/enteritis, restore appetite, and upregulate NK and CD8+ T-cell anti-tumor immunity.
Medical Tuina Manipulation, Ultrasound-Guided Acupotomy & Fire-Warming Moxibustion
For patients with lumbar disc herniation, cervical spondylosis, sciatica, frozen shoulder, knee osteoarthritis, or ankylosing spondylitis who wish to avoid spinal fusion or joint replacement. Combines ultrasound-guided micro-acupotomy (releasing calcified ligament adhesions through a 0.6 mm needle), biomechanical Tuina spinal decompression, herbal steam fumigation, and warm moxibustion—achieving 85%+ pain relief in 10 to 14 days.
Stage 3–4 Chronic Kidney Disease (CKD) Stabilization & Dialysis Delay Protocol
High rates of diabetes and hypertension in the Middle East frequently lead to Diabetic Nephropathy and elevated serum creatinine. Our integrative nephrology teams at Xiyuan Hospital, Shuguang Hospital, and Guangdong Provincial Hospital of Chinese Medicine combine micro-osmotic herbal transdermal iontophoresis, colonic detoxification enemas, and anti-fibrotic oral botanical granules to reduce proteinuria, lower serum creatinine/urea nitrogen, and preserve residual glomerular filtration rate (eGFR)—delaying or avoiding hemodialysis.
Endometrial Receptivity, Ovarian Reserve Activation & Male Andrology TCM
For couples preparing for IVF/ICSI or experiencing recurrent implantation failure, diminished ovarian reserve (low AMH), polycystic ovary syndrome (PCOS), or severe male oligoasthenoteratozoospermia. Pelvic blood-flow electro-acupuncture and cycle-phased herbal therapy increase uterine artery perfusion and double clinical pregnancy rates.
Autonomic Nervous System Reset, Chronic Insomnia, Burnout & Cardiopulmonary Qi Recovery
Conducted in tranquil garden hospital pavilions in Hangzhou (West Lake), Hainan Boao, or Beijing. Combines pulse-and-tongue constitutional diagnosis by National Master TCM Physicians with cranial auricular acupuncture, medicinal bath hydrotherapy, Qigong breathing therapy, and customized Halal longevity tonics.
China's Flagship National Medical Centers & International Medical Wings (IMS)
In China's hospital grading system, Class-A Tertiary (San-Jia / 三甲) is the highest statutory accreditation awarded by the National Health Commission, while JCI (Joint Commission International), CAP (College of American Pathologists), ISO15189, and ACHS certify international clinical governance. Every partner hospital below features a dedicated International Medical Services (IMS) VIP Wing with single-family suites, English/Arabic coordination, and direct green-channel access to China's top academician physicians.
Five-Star Private Family Recovery Suites & Halal Hospitality
Spacious 65–120 m² private hospital suites featuring separate family reception lounges, companion beds, Qibla prayer direction markers, Arabic satellite TV, Halal gourmet room service, and 24-hour bilingual nursing care.
Hainan Boao Lecheng International Medical Tourism Pilot Zone (30-Day Visa-Free Island)
Granted special "Four-First" regulatory privileges by the Chinese central government, Boao Lecheng (home to Ruijin Hainan Hospital, Boao Super Hospital, and West China Lecheng Hospital) is authorized to import and administer any newly FDA-, EMA-, or PMDA-approved orphan drug, targeted oncology therapeutic, radioligand (177Lu-PSMA), BNCT device, or cochlear/ophthalmic implant immediately—combined with 30-day visa-free entry for 85+ countries and tropical beachfront convalescence.
1. Peking Union Medical College Hospital (PUMCH / 北京协和医院)
Founded in 1921 by the Rockefeller Foundation; ranked #1 Comprehensive Hospital in China for 15 consecutive years (Fudan Hospital Rankings). National referral authority for complex, rare, undiagnosed multisystem diseases, rheumatology/immunology, endocrinology, pancreatic surgery, and gynecological oncology.
2. Cancer Hospital, Chinese Academy of Medical Sciences (CAMS / 国家癌症中心)
China's #1 Oncology Hospital. Global leader in thoracic lung surgery, esophageal/gastric cancer, colorectal NOSES surgery, precision intensity-modulated radiotherapy, and novel ADC/bispecific antibody clinical trials.
3. Fuwai Hospital, CAMS (中国医学科学院阜外医院)
The world's largest cardiovascular specialty hospital (18,000+ open-heart operations & 45,000+ interventional procedures/year). Premier center for complex aortic arch surgery, TAVR, pediatric congenital heart repair, coronary bypass, and artificial heart implantation.
4. Beijing Tiantan Hospital (首都医科大学附属北京天坛医院)
National Center for Neurological Disorders. World authority in brainstem cavernoma/glioma microsurgery, skull base chordoma, giant intracranial aneurysms, Moyamoya bypass, Remebot robotic epilepsy surgery, and Parkinson's DBS.
5. Peking University People's Hospital (北京大学人民医院)
Birthplace of the "Beijing Protocol" Haploidentical Stem Cell Transplantation (world's largest allogeneic HSCT center performing 1,300+ transplants/year) and National Center for Musculoskeletal 3D-Printed Bone Tumor Reconstruction.
6. Guang'anmen Hospital, CACMS (中国中医科学院广安门医院)
WHO Collaborating Center for Traditional Medicine. Renowned among foreign dignitaries and Gulf royal families for integrative TCM oncology, diabetic nephropathy/retinopathy, rheumatology, and non-surgical spine therapy.
7. Ruijin Hospital, Shanghai Jiao Tong University (上海交通大学医学院附属瑞金医院)
Home to China's National Center for Translational Medicine. Global leader in commercial & dual-target CAR-T therapy for lymphoma/myeloma/lupus, robotic pancreatic & gastric surgery, endocrine tumors, and metabolic diabetes care.
8. Zhongshan Hospital, Fudan University (复旦大学附属中山医院)
World powerhouse in hepatocellular carcinoma (ALPPS & liver resection), complex structural heart interventions (TAVR/MitraClip), robotic colorectal/thoracic surgery, and uEXPLORER Total-Body PET-CT executive diagnostics.
9. Huashan Hospital, Fudan University (复旦大学附属华山医院)
First JCI-accredited Class-A Tertiary public hospital in Shanghai. Features a world-famous International Medical Center, #1 Infectious Diseases & Neurology, and one of the world's top 3 Neurosurgery and Brachial Plexus Hand Surgery centers.
10. Shanghai Proton and Heavy Ion Center (SPHIC / 上海市质子重离子医院) & FUSCC
Jointly operated with Fudan University Shanghai Cancer Center. Equipped with Siemens synchrotron Proton & Carbon Heavy-Ion beams for chordoma, sarcoma, pancreatic, liver, prostate, and recurrent head/neck cancers.
11. Renji Hospital, SJTU (上海交通大学医学院附属仁济医院)
World's #1 Living-Donor Pediatric and Adult Liver Transplant Center (800+ liver transplants/year), and national leader in rheumatology (autoimmune lupus CAR-T), gastroenterology, and urology.
12. Sun Yat-sen University Cancer Center (SYSUCC / 中山大学肿瘤防治中心)
Ranked #1 globally for Nasopharyngeal Carcinoma (NPC) research and therapy, and top-3 in China for hepatic arterial infusion chemotherapy (HAIC) in liver cancer, robotic urology, and immunotherapy trials.
13. The First Affiliated Hospital of Sun Yat-sen University & Guangzhou Medical Univ.
Pioneered "Ischemia-Free Organ Care" (normothermic machine perfusion keeping livers and hearts beating during surgery) and Tubeless Non-Intubated Uniportal VATS Thoracic Surgery under Academician He Jianxing.
14. Nanfang Hospital & The University of Hong Kong-Shenzhen Hospital (HKU-SZH)
Nanfang Hospital leads South China in curative Beta-Thalassemia Major stem cell transplantation and gene therapy; HKU-Shenzhen Hospital offers Hong Kong/Western clinical governance with international direct billing.
15. The First Affiliated Hospital, Zhejiang University (FAHZU / 浙大一院)
JCI-accredited national medical center in scenic Hangzhou (home to one of China's largest Muslim communities and historic Phoenix Mosque). World leader in CAR-T cellular immunotherapy, bone marrow transplant, and hepatobiliary surgery.
16. Boao Super Hospital & Ruijin Hainan Hospital (博鳌超级医院 / 瑞金海南医院)
Located in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Provides immediate access to newly FDA/EMA-approved global drugs, BNCT boron neutron capture therapy, and tropical resort recovery.
Seamless International Insurance Direct Settlement & GCC Ministry of Health Sponsorship Coordination
Our International Financial Clearance & Insurance Desk works directly with Middle Eastern Ministries of Health (Treatment Abroad Committees), Military/Royal Medical Offices, Third-Party Administrators (TPAs), and global private health insurers so that eligible patients enjoy cashless inpatient treatment via Guarantee of Payment (GOP) or receive fully compliant, embassy-authenticated ICD-10/CPT claim dossiers for rapid reimbursement.
1. GCC Government & Royal Medical Sponsorships
- • Saudi Arabia (KSA): Ministry of Health (MOH) High Medical Committee Referrals, Royal Court Medical Orders, MODA (Armed Forces Medical Services), and National Guard Health Affairs.
- • United Arab Emirates (UAE): Department of Health Abu Dhabi (DOH / Thiqa International Patient Care), Dubai Health Authority (DHA Overseas Treatment Office), and Presidential Court Medical Office.
- • State of Qatar: Ministry of Public Health (MOPH) Medical Relations & Treatment Abroad Department, and Hamad Medical Corporation (HMC) Committee referrals.
- • Kuwait, Oman & Bahrain: Kuwait MOH Overseas Treatment Office, Oman MOH Treatment Abroad Committee, and Bahrain Supreme Council of Health.
2. Direct-Billing Private Insurers & TPAs
- • Global International Plans: Bupa Global, Cigna Global Health Options, Allianz Care, Aetna International, MSH International, Henner, Now Health International, and AXA Global Healthcare.
- • Middle East & GCC Insurers: Bupa Arabia, Tawuniya (The Company for Cooperative Insurance, KSA), Medgulf, Daman / Thiqa (UAE), Sukoon Insurance (Oman Insurance Company), GIG Gulf, QLM Life & Medical Insurance (Qatar), and Gulf Insurance Group (Kuwait).
- • Regional TPAs: NEXTCARE, NAS Neuron, GlobeMed, MedNet, and Almadallah.
How Our 48-Hour Insurance Pre-Authorization (GOP) Process Works
Send your insurance card (front/back) and passport copy via WhatsApp (+86 180 7951 9899).
Our Chinese professor completes the insurer's Medical Report, ICD-10 diagnosis, and CPT cost breakdown.
Insurer or Embassy Medical Attaché issues a direct Guarantee of Payment (GOP) to the hospital's International Wing.
Hospital bills the insurer/TPA directly; self-pay patients receive itemized English/Arabic invoices & UnionPay/Visa/Mastercard/Wire receipts.
Our coordinators prepare standardized clinical justification reports for GCC Overseas Treatment Committees (High Medical Committees) when a required therapy—such as Dual-Target CAR-T, Carbon Heavy-Ion Radiotherapy, or ALPPS liver surgery—is unavailable locally.
Accepted International Payment & Escrow Channels
For self-funded or partially insured patients, all payments are made directly to the official hospital account (zero hidden agency markups on hospital medical bills). Partner hospitals accept:
- • International SWIFT Bank Wire (USD, EUR, SAR, AED, QAR, CNY)
- • International Credit/Debit Cards (Visa, Mastercard, American Express, UnionPay) at Hospital VIP Cashier
- • Embassy Medical Attaché Letter of Financial Guarantee (LOG)
Middle East to China Medical Visa Matrix, 30-Day Visa-Free Policies & Emergency Port Visas
Entry into China for medical treatment from the Arabian Gulf and wider Middle East has never been faster. Citizens of all six GCC states (Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain) enjoy 30-day visa-free entry into all Chinese mainland cities, while patients from Jordan, Egypt, Iraq, Lebanon, and North Africa receive 48-hour expedited Humanitarian/Medical Visas (S2 / M / Q2) backed by official Tertiary Hospital and Municipal Foreign Affairs Office invitation letters.
2026 Middle East & GCC to China Medical Entry & Direct Flight Matrix
Includes ordinary passport visa-free status, long-stay medical visa extensions, and non-stop flight corridors.
| Country of Origin | Immediate Entry Policy (Ordinary Passport) | Long-Term Treatment (>30 Days) Pathway | Non-Stop Direct Flights to China Hubs | Flight Time |
|---|---|---|---|---|
| 🇸🇦 Saudi Arabia (Riyadh, Jeddah, Dammam) | 30-Day Visa-Free Entry (All Mainland China + Hainan) | S2 Medical Visa (90–180 days) OR enter Visa-Free and our legal team converts/extends stay at Hospital PSB Desk | Saudia, Air China, China Southern, China Eastern to Beijing (PEK/PKX), Shanghai (PVG), Guangzhou (CAN), Shenzhen (SZX) | 7.5 – 9.0 hrs |
| 🇦🇪 United Arab Emirates (Dubai, Abu Dhabi) | 30-Day Bilateral Mutual Visa-Free Entry | In-country PSB Medical Stay Permit extension (up to 180 days) or pre-departure S2 Multi-Entry Medical Visa | Emirates, Etihad, Air China, China Southern, China Eastern to Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou | 6.5 – 8.0 hrs |
| 🇶🇦 State of Qatar (Doha) | 30-Day Bilateral Mutual Visa-Free Entry | In-country PSB Medical Stay Permit extension or S2 Medical Visa for patient + up to 5 family companions | Qatar Airways, China Southern, Xiamen Air to Beijing, Shanghai, Guangzhou, Hangzhou, Chengdu | 7.0 – 8.5 hrs |
| 🇰🇼 State of Kuwait (Kuwait City) | 30-Day Visa-Free Entry (All Mainland China + Hainan) | S2 Medical Visa (48h Express at Chinese Embassy Kuwait) or in-country PSB hospital extension | Kuwait Airways (Direct to Guangzhou CAN) + 1-stop via Dubai/Doha to Beijing & Shanghai | 7.5 – 9.0 hrs |
| 🇴🇲 Sultanate of Oman (Muscat) | 30-Day Visa-Free Entry (All Mainland China + Hainan) | In-country PSB Medical Stay Permit extension or 48h Express S2 Medical Visa via Muscat | Oman Air / China Eastern (Muscat to Guangzhou/Beijing) + seamless Gulf hub connections | 6.5 – 8.0 hrs |
| 🇧🇭 Kingdom of Bahrain (Manama) | 30-Day Visa-Free Entry (All Mainland China + Hainan) | In-country PSB Medical Stay Permit extension or Express S2 Medical Visa | Gulf Air (Direct to Shanghai PVG & Guangzhou CAN) | 7.5 – 8.5 hrs |
| 🇯🇴 Jordan, 🇪🇬 Egypt, 🇮🇶 Iraq & MENA | 48-Hour Green-Channel Medical Visa (S2 / M) + Port Visa on Arrival for Emergencies | Official Hospital Admission + Municipal Government Invitation Letter issued within 24h; extendable inside China up to 180 days | EgyptAir (Direct Cairo to Beijing, Shanghai, Guangzhou, Hangzhou); Iraqi Airways (Baghdad to Guangzhou/Beijing) | 8.5 – 10.5 hrs |
Freshly prepared Halal Middle Eastern and Chinese Islamic cuisine (lamb mandi/kabsa, grilled chicken, lentil soups, Arabic bread, dates, and clinical oncology/renal therapeutic diets) delivered to the patient's bedside and family suite daily.
Every VIP hospital suite includes a prayer mat, Holy Quran, Qibla compass indicator, and Wudu-friendly washrooms. We also arrange Friday Jummah transport to historic mosques in Beijing (Niujie Mosque), Shanghai (Fuyou Road Mosque), Guangzhou (Huaisheng Mosque), and Hangzhou (Phoenix Mosque).
Strict "Female Patient Only" door signage protocols, female-only nursing shifts, female ultrasound/MRI technicians, and female Arabic medical interpreters upon request to uphold Islamic modesty at every clinical step.
For families staying 2 to 8 weeks during CAR-T, proton therapy, or transplant recovery, we arrange 2- and 3-bedroom luxury serviced apartments (Ascott, Oakwood, Marriott Executive Apartments) within 500 meters of the hospital with full kitchens.
Patient Testimonials & Clinical Case Studies from Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, Egypt & Iraq
Read detailed clinical journeys and first-person reviews from Middle Eastern patients and families who traveled to Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, and Hainan Boao for life-saving CAR-T cell therapy, robotic oncology surgery, proton/heavy-ion radiotherapy, haploidentical bone marrow transplantation, and integrative TCM neuro-rehabilitation. (Patient names are formatted per family privacy preferences; full anonymized clinical summaries are available during consultation.)
Sheikh Abdullah Al-Otaibi (Age 58) • Relapsed Double-Hit DLBCL Lymphoma
"After my father's diffuse large B-cell lymphoma relapsed within four months of R-CHOP and salvage DHAP chemotherapy in Riyadh, a hospital in Houston quoted us $580,000 USD with a seven-week waitlist just for apheresis. Through the Sino-Gulf Referral Desk, we had a Zoom consultation with Professor Zhao's hematology team at Ruijin Hospital Shanghai within 36 hours. Because Saudi citizens now enter China visa-free, we flew directly from Riyadh to Shanghai two days later. T-cell collection took place the morning after arrival, and my father received Dual CD19/CD22 CAR-T infusion on Day 14. He experienced only a mild two-day fever (Grade 1 CRS) that resolved immediately. His Day-28 and Month-12 PET-CT scans showed 100% complete metabolic remission (Deauville Score 1). The total cost including our 6-week VIP suite and Arabic interpreter was under $82,000 USD. Wallahi, the speed and medical precision saved my father's life."
Baby Layan Al-Ghamdi (Age 9 Months) • Biliary Atresia & Decompensated Cirrhosis
"Our daughter Layan had a failed Kasai procedure and her bilirubin rose above 380 µmol/L with severe ascites. Renji Hospital in Shanghai is the world's largest pediatric liver transplant center, performing over 400 pediatric living-donor surgeries a year. Once the Saudi Embassy authenticated our family kinship documents, I donated 220 grams of my left lateral liver lobe via a 100% laparoscopic robotic-assisted procedure. I was walking on Day 2 and discharged on Day 5 with only a tiny bikini-line incision. Layan's microsurgical hepatic artery anastomosis succeeded on the first attempt, her bilirubin normalized within 10 days, and today in Jeddah she is a healthy, playful toddler."
Eng. Khalid Al-Dosari (Age 62) • Complex Thoracoabdominal Aortic Dissection
"Surgeons in two countries told my family that my chronic Type A/B dissecting aortic aneurysm involving the subclavian and carotid branches carried a 25% risk of paraplegia or stroke during open surgery. At Fuwai Hospital in Beijing, where they perform over 1,500 aortic operations a year using 'Sun's Procedure,' the surgical team completed my total aortic arch replacement and stented frozen elephant trunk implantation in under 4.5 hours without a single neurological complication. The Arabic concierge team arranged Halal meals and daily WhatsApp updates for my brothers in Dammam."
Mr. Tariq Al-Maktoum (Age 49) • Clival Skull-Base Chordoma Compressing Brainstem
"My clival chordoma was wrapped around the basilar artery and optic nerve, causing double vision. First, the skull-base neurosurgery team at Huashan Hospital performed an endoscopic endonasal resection through my nose—with zero external scars—debulking 92% of the tumor off the brainstem. Three weeks later, I transferred 25 minutes across Shanghai to SPHIC for 16 fractions of Carbon Heavy-Ion (12C6+) pencil-beam radiotherapy. Because carbon ions stop at the Bragg Peak, my optic chiasm and brainstem received almost zero radiation. My diplopia vanished completely, and two years later my 3.0T MRI in Dubai shows zero tumor regrowth."
H.E. Mansour Al-Nahyan (Age 64) • Gleason 4+3 Localized Prostate Adenocarcinoma
"Flying non-stop from Abu Dhabi to Shanghai with visa-free entry was effortless. Within 24 hours of arrival, I completed a 68Ga-PSMA PET-CT and 3.0T multiparametric MRI confirming organ-confined disease. Using the Da Vinci Single-Port (SP) robot and Retzius-sparing nerve preservation, the chief urologist removed my prostate through a single 2.5 cm incision with less than 40 mL of blood loss. When my catheter was removed on Day 7, I had 100% urinary continence from the very first day—no pads needed—and my PSA remains undetectable (<0.008 ng/mL)."
Mrs. Fatima Al-Qasimi (Age 53) • Asymptomatic 7mm Stage IA1 Lung Adenocarcinoma
"My husband and I booked the 3-Day Royal Diamond Executive Checkup in Shanghai during a business trip. Although I had zero symptoms, the AI-assisted low-dose chest CT and ctDNA methylation liquid biopsy flagged a 7 mm mixed ground-glass nodule in my right upper lung lobe. Two days later at Shanghai Pulmonary Hospital, I underwent a 'Tubeless' non-intubated single-port thoracoscopic wedge resection with an all-female nursing and anesthesia team. Pathology confirmed Stage IA1 minimally invasive adenocarcinoma—100% cured by surgery alone without any chemotherapy or radiation! I flew back to Dubai five days later."
Mr. Hamad Al-Thani (Age 61) • Pentarefractory Multiple Myeloma with Bone Lesions
"My father's IgG-kappa Multiple Myeloma had progressed after Bortezomib, Lenalidomide, Pomalidomide, Daratumumab, and an autologous stem cell transplant. He was wheelchair-bound with severe spinal bone pain and a free kappa light chain above 1,800 mg/L. We flew Qatar Airways direct from Doha to Hangzhou. At The First Affiliated Hospital of Zhejiang University (FAHZU), Professor Huang's team enrolled him in a humanized BCMA CAR-T protocol. By Day 21 post-infusion, his serum free light chains dropped to normal range, and his bone marrow flow cytometry achieved Stringent Complete Remission (sCR, MRD-negative at 10⁻⁶). Alongside integrative TCM acupuncture, he walked out of the hospital without a cane."
Hajj Nasser Al-Marri (Age 67) • Left Middle Cerebral Artery Stroke Hemiplegia & Aphasia
"Four months after a severe ischemic stroke, my father still could not move his right arm or leg, required a nasogastric feeding tube due to swallowing paralysis, and could not speak clearly. During a 35-day inpatient program in China combining daily 'Xing Nao Kai Qiao' brain-awakening acupuncture, hyperbaric oxygen therapy, transcranial magnetic stimulation, and Brain-Computer Interface (BCI) robotic gait training, the transformation was miraculous. In Week 2, his swallowing reflex returned and the feeding tube was removed; by Week 5, he was walking 150 meters with a quad cane and conversing in Arabic."
Mr. Bader Al-Sabah (Age 55) • Borderline Resectable Pancreatic Head Cancer
"Two European centers told me my 3.8 cm pancreatic head tumor was inoperable because it invaded 180 degrees of the superior mesenteric-portal vein confluence, and recommended palliative chemotherapy only. In Shanghai, the pancreatic MDT team administered 4 cycles of neoadjuvant mFOLFIRINOX + Claudin18.2 targeted therapy, shrinking the tumor by 45%, and then performed a radical Whipple procedure with portal vein segmental resection and reconstruction plus intraoperative radiotherapy. All 28 resected lymph nodes and surgical margins were negative (R0). Twenty months later, my CA19-9 is 11 U/mL and my PET-CT is completely clean."
Ms. Dalal Al-Mutairi (Age 29) • Refractory Class IV Lupus Nephritis (SLE)
"For nine years I suffered from severe Systemic Lupus Erythematosus with Class IV Lupus Nephritis, enduring high-dose prednisone, mycophenolate, cyclophosphamide, belimumab, and rituximab, yet my 24-hour urine protein remained over 4.2 grams and I was facing kidney failure. In Shanghai, I received a single infusion of Dual CD19/BCMA CAR-T therapy. Within 60 days, my anti-dsDNA antibodies dropped to zero, complement C3/C4 normalized, my proteinuria fell below 0.2 g/24h, and my rheumatologist tapered me off all steroids and immunosuppressants completely. I finally have my life back."
Master Salim Al-Balushi (Age 8) • Transfusion-Dependent Beta-Thalassemia Major
"Our son Salim required blood transfusions every three weeks in Muscat since infancy, and neither his sisters nor international registries had a 10/10 HLA match. At Nanfang Hospital in Guangzhou, Professor Li's pediatric hematology team used the Chinese 'Beijing Protocol' so that I (his father, a 5/10 half-match) could donate peripheral blood stem cells. Neutrophil engraftment occurred on Day +12 with 99.8% donor chimerism and zero severe graft-versus-host disease. Salim's hemoglobin has remained steady at 13.4 g/dL for over a year without a single blood transfusion!"
Mr. Said Al-Harthy (Age 34) • Pelvic Acetabular Chondrosarcoma
"I was told abroad that removing my 9 cm pelvic bone tumor would require a hemipelvectomy amputation of my right leg. In Beijing, the musculoskeletal oncology team used 3D CT modeling to print a custom porous titanium hemipelvic and hip joint prosthesis in 96 hours. Using computer-navigated osteotomy guides and the TINAVI orthopedic robot, they resected the tumor with wide clean margins and implanted the 3D-printed pelvis. Today I walk unassisted and drive my car in Oman with both legs intact."
Hajj Isa Al-Khalifa (Age 66) • Wagner Grade 4 Diabetic Foot Gangrene & Ischemia
"Two vascular surgeons in Manama scheduled my father for a below-knee amputation because his plantar ulcer had exposed bone and occluded tibial arteries. We took Gulf Air direct from Bahrain to Shanghai. At Shanghai Sixth People's Hospital, surgeons performed infrapopliteal balloon angioplasty combined with 'Transverse Tibial Cortex Bone Transport'—a remarkable Chinese microsurgical technique that triggers a surge of new microvascular collateral vessels in the ischemic foot—paired with Halal TCM herbal wound dressings. Within five weeks, pink granulation tissue covered the bone, the ulcer healed completely, and my father's leg was saved."
Mrs. Mariam Al-Zayani (Age 46) • Post-Mastectomy Stage III Arm Lymphedema
"Three years after breast cancer surgery and axillary lymph node dissection, my right arm swelled to nearly twice the size of my left arm with recurrent cellulitis. In Shanghai, using ICG fluorescence lymphangiography and a 40x supermicroscope, the plastic microsurgery team performed 6 lymphaticovenular anastomoses (LVA) through tiny 1.5 cm skin incisions under local anesthesia. Within 72 hours, my arm circumference shrank by 4.8 cm, the heaviness disappeared, and I returned to Bahrain a week later."
Dr. Omar Al-Majali (Age 42) • Left Fronto-Insular Motor/Speech Area Glioma
"As a university professor in Amman, losing my ability to speak Arabic and English was my greatest fear when a 4.5 cm insular glioma was discovered inside my dominant left hemisphere. The Sino-Gulf team obtained my expedited medical visa in 48 hours. At Beijing Tiantan Hospital, the neurosurgical team performed an awake craniotomy with direct subcortical electrical stimulation while an Arabic medical interpreter tested my speech continuously during tumor removal. Intraoperative 3.0T MRI confirmed 99% gross total resection with 100% preservation of my speech and right-hand dexterity."
Mr. Yousef Haddad (Age 51) • Metastatic Claudin18.2+ Gastric Adenocarcinoma
"After SOX chemotherapy, nivolumab, and paclitaxel failed to control my gastric cancer peritoneal metastases and ascites, immunohistochemistry in Beijing showed 85% high Claudin18.2 expression (2+/3+). I received autologous Claudin18.2-targeted CAR-T cell therapy (Satri-cel / CT041 protocol), which was pioneered in China. Within six weeks, my peritoneal ascites resolved completely, target liver lesions shrank by 68% on 68Ga-FAPI PET-CT, and I gained 7 kg over the next four months."
Dr. Mahmoud El-Sayed (Age 60) • Giant 11cm Right-Lobe Hepatocellular Carcinoma
"In Cairo, my 11 cm liver tumor with right portal vein branch thrombus was staged BCLC-C and deemed unresectable because my left liver lobe was only 24% of total liver volume. Flying direct on EgyptAir from Cairo to Shanghai, the liver team performed two cycles of FOLFOX-HAIC (Hepatic Arterial Infusion Chemotherapy) plus Lenvatinib/PD-1, followed by Laparoscopic ALPPS Stage 1 & 2. My healthy left lobe hypertrophied to 44% in 12 days, allowing complete curative removal of the necrotic tumor. My AFP dropped from 14,200 ng/mL to 3.1 ng/mL!"
Little Zainab Al-Jabouri (Age 2) • Bilateral Group D Retinoblastoma
"Doctors in Baghdad and Istanbul told us we had to surgically remove (enucleate) our two-year-old daughter Zainab's right eye immediately to save her life. Refusing to give up her eye, we contacted the China Cross-Border Desk on WhatsApp and received an emergency medical visa invitation within 24 hours. At Xinhua Hospital in Shanghai, the pediatric interventional neuroradiology and ophthalmology team threaded a microcatheter into her 0.4 mm ophthalmic artery for 3 cycles of super-selective intra-arterial chemotherapy combined with laser thermotherapy. Today, both of Zainab's eyes are saved with functional vision and 100% tumor regression."
Configure Your Cross-Border Medical Plan & Dispatch Directly to WhatsApp (+86 180 7951 9899)
Select your country of origin, primary medical requirement, preferred transfer mode, and insurance/funding pathway below. Our interactive estimator calculates expected hospital turnaround, visa pathway, and reference budget, and formats a structured medical triage message ready to send via WhatsApp.
WhatsApp: +86 180 7951 9899
Staffed round-the-clock by bilingual Arabic, English, and Chinese medical coordinators, oncology case managers, and aviation medicine specialists. Send your medical reports (PDF/Photos) or DICOM scan links directly for a complimentary initial triage review.
• Latest Hospital Medical Report / Discharge Summary (English or Arabic)
• Pathology & Immunohistochemistry (IHC) / Genetic NGS Report (if oncology/hematology)
• Recent CT, MRI, or PET-CT reports (plus DICOM download link or video of scan slices)
• Current medication list, patient age, ECOG performance status (ambulatory vs. bedridden), and passport nationality
Comprehensive Clinical Protocols, Molecular Imaging Guide & Perioperative ERAS Compendium
Prepared for referring physicians, GCC Ministry of Health medical committees, royal medical offices, and patient families, this clinical compendium details the exact technical specifications, molecular biomarkers, surgical criteria, CAR-T cellular kinetics, and day-by-day inpatient recovery pathways utilized across our Chinese Class-A Tertiary (San-Jia) and JCI-accredited partner hospitals.
Clinical Guide to Next-Generation PET-CT & PET-MRI Molecular Tracers Available in China
While most general hospitals rely solely on standard fluorodeoxyglucose (18F-FDG) PET-CT, approximately 25% to 30% of malignant tumors—including signet-ring cell gastric carcinoma, mucinous colorectal adenocarcinoma, well-differentiated hepatocellular carcinoma, neuroendocrine tumors, clear-cell renal carcinoma, and prostate cancer—exhibit low glucose transporter (GLUT-1) expression and can appear falsely negative on routine FDG scans. Our nuclear medicine departments in Shanghai (Ruijin, Zhongshan, FUSCC, Huashan) and Beijing (PUMCH, 301 Hospital, Tiantan) synthesize over 14 specialized cyclotron radiotracers on-site daily to achieve near-100% lesion characterization.
1. 18F-FDG (Fluorodeoxyglucose) on uEXPLORER Total-Body PET-CT
Mechanism & Physics: Measures cellular hexokinase-mediated glucose trapping. When performed on the United Imaging uEXPLORER 194-cm axial field-of-view Total-Body scanner, all organs from the vertex of the skull to the toes are imaged simultaneously without bed-position stitching. Sensitivity is increased 40-fold compared to conventional 20-cm ring PET-CT systems, permitting either an ultra-fast 15-to-30-second breath-hold acquisition (eliminating respiratory motion blurring of 2 mm lung or liver subcapsular nodules) or an ultra-low radiation dose protocol (0.4–0.8 mSv, equivalent to a single transcontinental flight—safe for pediatric and pregnant patients when clinically indicated).
Primary Clinical Applications: Staging and restaging of lymphoma (Lugano Deauville 5-point scoring before and 28 days after CAR-T therapy), non-small cell lung cancer, esophageal squamous cell carcinoma, triple-negative breast cancer, melanoma, sarcoma, and evaluation of fever of unknown origin (FUO) or large-vessel vasculitis (Takayasu and giant cell arteritis).
2. 68Ga-FAPI-04 & 18F-FAPI-42 (Fibroblast Activation Protein Inhibitor)
Mechanism & Physics: Targets Fibroblast Activation Protein (FAP), a transmembrane serine protease overexpressed by cancer-associated fibroblasts (CAFs) in the desmoplastic stroma of over 90% of epithelial carcinomas. Because normal brain cortex, normal liver parenchyma, and the gastrointestinal tract have virtually zero physiological FAP uptake, 68Ga-FAPI produces extraordinary tumor-to-background contrast ratios (often 3x to 6x higher than 18F-FDG) without requiring patient fasting or blood glucose control—a major advantage for Middle Eastern patients with brittle Type 2 diabetes whose elevated blood glucose frequently degrades standard FDG PET scans.
Primary Clinical Applications: Gastric poorly cohesive and signet-ring cell carcinoma, pancreatic ductal adenocarcinoma, intrahepatic and perihilar cholangiocarcinoma, peritoneal carcinomatosis (detecting millimeter-scale omental and mesenteric implants prior to cytoreductive surgery and HIPEC), ovarian cancer, lobular breast carcinoma, and assessment of myocardial or hepatic fibrosis.
3. 68Ga-PSMA-11 & 18F-PSMA-1007 (Prostate-Specific Membrane Antigen)
Mechanism & Physics: Binds with nanomolar affinity to the extracellular domain of PSMA on prostate adenocarcinoma cells. Dual-tracer 18F-PSMA-1007 undergoes hepatobiliary clearance rather than rapid urinary bladder excretion, allowing crystal-clear delineation of local prostate bed recurrence and perivesical lymph nodes without urinary radioactivity masking the pelvis.
Primary Clinical Applications: Primary staging of intermediate-to-high-risk prostate cancer (Gleason Score ≥7 or PSA ≥10 ng/mL), localization of biochemical recurrence after radical prostatectomy when PSA is as low as 0.15–0.20 ng/mL, guidance of salvage stereotactic radiotherapy, and theranostic selection for 177Lu-PSMA-617 or 225Ac-PSMA targeted radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC).
4. 68Ga-DOTATATE / 68Ga-DOTANOC & Dual-Tracer HCC (11C-Acetate + 18F-FDG)
Mechanism & Physics: 68Ga-DOTATATE binds selectively to Somatostatin Receptor Subtype 2 (SSTR2) on well-differentiated neuroendocrine neoplasms, while 11C-Acetate traces cell membrane lipid synthesis in well-differentiated hepatocellular carcinoma (HCC) that lacks FDG avidity.
Primary Clinical Applications: Identifying occult primary pancreatic, ileal, or bronchial neuroendocrine tumors (NET G1/G2), glomus tumors, pheochromocytoma, and meningioma margins near the cavernous sinus; dual-tracer 11C-Acetate + 18F-FDG PET-CT provides 98% sensitivity in staging multifocal liver cancer prior to ALPPS resection or living-donor liver transplantation, accurately predicting microvascular invasion (MVI) grade.
5. Neuro-Oncology Amino Acid PET (11C-Methionine / 18F-FET) & Parkinson's Dopamine PET (18F-DTBZ / 18F-DOPA)
Mechanism & Physics: Amino acid tracers cross the blood-brain barrier via L-type amino acid transporters (LAT1) that are highly upregulated in glioma cells but quiescent in normal brain tissue or radiation necrosis.
Primary Clinical Applications: Differentiating true glioblastoma or astrocytoma recurrence from post-radiation pseudoprogression or necrosis; guiding Remebot stereotactic biopsy to the most metabolically aggressive anaplastic focus of a non-enhancing brain tumor; and quantifying presynaptic striatal vesicular monoamine transporter 2 (VMAT2) density via 18F-DTBZ PET to distinguish idiopathic Parkinson's disease (eligible for Deep Brain Stimulation) from multiple system atrophy (MSA) or progressive supranuclear palsy (PSP).
6. Alzheimer's Cognitive PET (18F-AV45 Amyloid & 18F-MK6240 Tau PET-MRI) & 68Ga-Pentixafor CXCR4 PET
Mechanism & Physics: 18F-AV45 and 18F-MK6240 directly visualize cortical beta-amyloid neuritic plaques and neurofibrillary tau tangles 10 to 15 years before severe dementia symptoms manifest. Meanwhile, 68Ga-Pentixafor (CXCR4-targeted PET) developed and clinically validated at Ruijin and PUMCH non-invasively lateralizes aldosterone-producing adrenal adenomas (Conn's syndrome causing resistant hypertension) without invasive adrenal vein sampling.
Primary Clinical Applications: Early confirmation of prodromal Alzheimer's disease to determine eligibility for anti-amyloid monoclonal antibody therapy (Lecanemab / Donanemab), and non-invasive surgical cure of endocrine secondary hypertension via single-port retroperitoneoscopic adrenal adenoma enucleation.
Painless Magnifying Endoscopy (ESD Cure), Liquid Biopsy & Trio Whole-Genome Sequencing Protocols
Optical Magnifying Endoscopy & Curative ESD
In China, routine upper and lower gastrointestinal endoscopy incorporates Narrow-Band Imaging (NBI), Blue Laser Imaging (BLI), Linked Color Imaging (LCI), chromoendoscopy (indigo carmine and Lugol's iodine), and 80x–135x optical zoom magnification. This allows endoscopists to visualize sub-millimeter intrapapillary capillary loops (IPCL) of the esophagus and microvascular/microsurface (VS) pit patterns of the stomach and colon in real time.
When an early intramucosal carcinoma or high-grade intraepithelial neoplasia (Stage T1a) is detected during checkup, our therapeutic endoscopy professors at Zhongshan Hospital, Ruijin Hospital, or PUMCH perform Endoscopic Submucosal Dissection (ESD), Submucosal Tunneling Endoscopic Resection (STER), or Peroral Endoscopic Myotomy (POEM for achalasia) through the natural lumen—peeling the entire lesion off the muscularis propria in one piece with negative margins, achieving a 99% 5-year cure rate while preserving 100% of the native stomach, esophagus, or colon.
Ultra-Deep ctDNA MRD & Liquid Biopsy
Our CAP- and ISO15189-certified molecular pathology laboratories perform two distinct tiers of cell-free circulating tumor DNA (ctDNA) testing:
1. Multi-Cancer Early Detection (MCED) Methylation Screening: Analyzes over 100,000 targeted CpG methylation haplotype blocks in plasma cell-free DNA to detect pre-symptomatic Stage I/II malignancies across 50+ histological types, including lethal cancers that lack standard screening tests (pancreatic, ovarian, hepatobiliary, esophageal, sarcoma, and lymphoma).
2. Tumor-Informed Minimal Residual Disease (MRD) Tracking: After curative cancer surgery in China, whole-exome sequencing of the resected tumor tissue identifies 16 to 50 patient-specific somatic clonal mutations. Customized ultra-deep multiplex PCR (100,000x read depth, 0.004% VAF limit of detection) monitors peripheral blood every 3 months in the patient's home country, detecting molecular relapse 6 to 9 months earlier than CT or serum tumor markers.
Consanguinity-Focused Rare Disease Trio WGS
Across the Arabian Peninsula and wider MENA region, autosomal recessive genetic conditions occur with higher frequency. Our Medical Genetics Centers at PUMCH, Beijing Children's Hospital, and Shanghai Children's Medical Center perform Trio Whole-Genome Sequencing (30x–50x coverage of all 3.2 billion base pairs across exons, deep intronic splice sites, structural copy-number variations, and mitochondrial DNA) coupled with RNA-seq transcriptomics and tandem mass spectrometry metabolomics.
This integrated pipeline resolves previously undiagnosed pediatric epileptic encephalopathies, primary immunodeficiencies (SCID/CGD), lysosomal storage disorders, spinal muscular atrophy (SMA), congenital muscular dystrophies, and hereditary cardiomyopathies within 7 to 10 days—identifying actionable enzyme replacement therapies, antisense oligonucleotides, or curative umbilical cord blood / haploidentical stem cell transplantation pathways.
Detailed Clinical Protocols for Complex Solid Tumors, Cardiovascular Reconstruction & Organ Care
Below are the standardized clinical workflows executed by our multidisciplinary surgical teams for patients referred from Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, Egypt, and Iraq.
Protocol A: Pancreatic Ductal Adenocarcinoma (Conversion + Radical Vascular Resection)
Pre-Operative Workup (Days 1–3): Thin-slice (0.625 mm) pancreatic triphasic CT angiography with 3D vascular reconstruction of the superior mesenteric artery (SMA), celiac trunk, common hepatic artery, and portal-mesenteric vein axis; 68Ga-FAPI-04 PET-CT to rule out occult peritoneal or hepatic micrometastases; EUS-FNB core biopsy with 1,021-gene NGS (screening for KRAS G12C/G12D, BRCA1/2, PALB2, NTRK, and Claudin18.2 IHC).
Surgical & Conversion Strategy: For upfront resectable tumors, Da Vinci Xi Robotic or Open Radical Antegrade Modular Pancreatosplenectomy (RAMPS) or Artery-First Pancreaticoduodenectomy (Whipple) with Heidelberg triangle total mesopancreas excision is performed. For locally advanced tumors with >180° portal/SMV encasement, 4–6 cycles of tailored conversion therapy (mFOLFIRINOX, Gemcitabine/Nab-Paclitaxel + PD-1/Claudin18.2 antibody, or Stereotactic Body Radiotherapy) are followed by radical resection with autologous internal jugular/renal vein or bovine pericardial interposition grafting and intraoperative electron radiotherapy (IOERT) or Irreversible Electroporation (NanoKnife IRE).
Post-Operative ERAS Recovery: Somatostatin analogue infusion, early enteral nutrition by Day 3, drain amylase monitoring on Days 3 and 5, and discharge between Days 10 and 14.
Protocol B: Advanced Hepatocellular Carcinoma (HAIC Conversion, Y-90 SIRT & ALPPS)
Pre-Operative Workup (Days 1–2): Gd-EOB-DTPA (Primovist) hepatocyte-specific 3.0T MRI, Indocyanine Green 15-minute retention rate (ICG-R15) liver functional reserve testing, 3D IQQA virtual liver volumetry calculating exact Future Liver Remnant (FLR) percentage, and triple serum markers (AFP, AFP-L3%, and PIVKA-II / DCP).
Multimodal Downstaging & Resection: For giant (>10 cm) or portal-vein-thrombus (PVTT Vp3/Vp4) liver tumors, our hepatobiliary teams utilize the landmark Chinese FOLFOX-HAIC (Hepatic Arterial Infusion Chemotherapy via implanted microcatheter) + Lenvatinib/Bevacizumab + PD-1/PD-L1 triple conversion regimen or Yttrium-90 (90Y) Resin/Glass Microsphere Selective Internal Radiation Therapy (SIRT). This achieves an objective response rate exceeding 65%, downstaging previously unresectable tumors to curative anatomical hepatectomy or two-stage laparoscopic ALPPS.
Adjuvant Recurrence Prevention: Post-resection ctDNA MRD surveillance, adjuvant transarterial chemoembolization (TACE) at Week 4 for high-risk microvascular invasion (MVI-positive) cases, and GPC3 neoantigen vaccine or CAR-T consolidation.
Protocol C: Locally Advanced Rectal & Gastric Cancer (Total Neoadjuvant + Sphincter-Saving NOSES)
Rectal Cancer Organ & Sphincter Preservation: For distal rectal adenocarcinoma located 1.5 to 5.0 cm from the anal verge, patients undergo high-resolution 3.0T pelvic MRI (assessing circumferential resection margin CRM and extramural vascular invasion EMVI). In MSI-High / dMMR patients (~8%–12% of cases), single-agent or dual PD-1/CTLA-4 immunotherapy (Dostarlizumab / Cadonilimab / Envafolimab) achieves 75%–90% clinical complete response (cCR), allowing a non-operative "Watch and Wait" organ preservation strategy. For MSS tumors, Total Neoadjuvant Therapy (TNT) followed by Da Vinci Xi Robotic Intersphincteric Resection (ISR) or Transanal Total Mesorectal Excision (TaTME) preserves anal continence in over 92% of patients.
Gastric Cancer Peritoneal Metastasis (CRS + HIPEC): For gastric cancer with positive peritoneal cytology (CY1) or P1–P2 peritoneal seeding, bidirectional neoadjuvant intraperitoneal and systemic paclitaxel (NIPS) followed by complete cytoreductive surgery (CRS) and closed-abdomen hyperthermic intraperitoneal chemotherapy (HIPEC at 43.0°C for 60 minutes) triples median survival.
Protocol D: Complex Aortic Arch Dissection, Valve Repair & Diabetic Coronary Bypass
Total Arch & Thoracoabdominal Reconstruction: Utilizing moderate hypothermic circulatory arrest (25°C–28°C) with bilateral selective antegrade cerebral perfusion and near-infrared spectroscopy (NIRS) regional cerebral oximetry monitoring, Fuwai and Anzhen cardiovascular surgeons perform Sun's Total Arch Replacement with a 4-branched graft and stented elephant trunk in 3.5 to 4.5 hours, followed by thoracic endovascular aortic repair (TEVAR) completion if needed.
Diabetic Multi-Vessel Coronary Disease: Because patients from the GCC frequently present with diffuse small-caliber coronary atherosclerosis and multiple prior occluded stents ("full metal jacket"), our cardiac surgeons perform One-Stop Hybrid Coronary Revascularization—combining minimally invasive direct coronary artery bypass (MIDCAB: Left Internal Mammary Artery to LAD through a 5 cm left mini-thoracotomy without sternotomy or cardiopulmonary bypass) with drug-eluting balloon/stent angioplasty of non-LAD vessels in the same hybrid operating room.
Inpatient Safety Governance: CRS/ICANS Cytokine Control, Class-100 Laminar Cabins & Robotic ERAS
1. Grading & Pre-Emptive Control of CAR-T Cytokine Release Syndrome (CRS)
A critical question asked by referring hematologists in Riyadh, Dubai, and Doha is how Chinese CAR-T centers achieve Grade ≥3 severe CRS rates below 4%. Our hematology departments implement an Early Biomarker-Guided Pre-Emptive Intervention Algorithm based on ASTCT consensus grading:
• Grade 1 CRS (Fever ≥38.0°C without hypotension or hypoxia): Immediate broad-spectrum empirical infection workup, intravenous hydration, cooling blankets, and early administration of Tocilizumab (8 mg/kg IV) if fever persists >24 hours or if serum IL-6 rises >5-fold within 12 hours—halting the cytokine cascade before vascular leak or organ toxicity develops.
• Grade 2 CRS (Fever with fluid-responsive hypotension or low-flow nasal oxygen): Immediate Tocilizumab + low-dose Dexamethasone (10 mg IV q12h); if refractory within 12 hours, second-line Siltuximab (direct IL-6 neutralizer, which does not transiently elevate CNS IL-6), Anakinra (IL-1 receptor antagonist), or Ruxolitinib (JAK1/2 inhibitor) is initiated.
• ICANS Neuroprotection: Twice-daily ICE (Immune Effector Cell-Associated Encephalopathy) 10-point scoring conducted in Arabic, continuous EEG monitoring, and prophylactic Levetiracetam (500 mg BID from Day 0 to Day +30).
2. Haploidentical HSCT ("Beijing Protocol") Conditioning & GVHD Prophylaxis
For children and adults undergoing curative Haploidentical Allogeneic Stem Cell Transplantation for Beta-Thalassemia Major, Sickle Cell Disease, or Acute Leukemia inside our ISO Class-100 positive-pressure HEPA laminar-flow sterile cabins:
• Donor Selection Algorithm: When multiple half-matched (5/10 HLA) family members are available, we screen donor-specific anti-HLA antibodies (DSA mean fluorescence intensity <2,000; if positive, Rituximab + bortezomib + plasmapheresis desensitization is performed prior to conditioning) and prioritize young male, non-inherited maternal antigen (NIMA)-mismatched, and NK-cell KIR-ligand-favorable donors.
• Conditioning & Graft Engineering: Individualized pharmacokinetic-guided Busulfan (targeted AUC) + Cyclophosphamide + Fludarabine + Rabbit Anti-Thymocyte Globulin (rATG), followed by unmanipulated G-CSF-primed bone marrow + peripheral blood stem cell infusion.
• GVHD & Viral Shield: Letermovir prophylaxis eliminates CMV reactivation; Ruxolitinib + Mesenchymal Stem Cell (MSC) co-infusion keeps severe Grade III–IV acute Graft-Versus-Host Disease below 6%.
3. Enhanced Recovery After Robotic Surgery (ERAS) & Thrombosis Prevention
Every international surgical patient is managed under a multidisciplinary ERAS protocol led by surgical, anesthesiology, clinical nutrition, rehabilitation, and TCM teams:
• Prehabilitation (48–72h Pre-Op): Cardiopulmonary inspiratory muscle training, iron/albumin optimization, carbohydrate loading 2 hours before anesthesia (replacing prolonged starvation), and thromboelastography (TEG) baseline coagulation mapping.
• Opioid-Sparing Multimodal Anesthesia: Ultrasound-guided transversus abdominis plane (TAP), paravertebral, or erector spinae nerve blocks combined with goal-directed fluid therapy and core normothermia.
• Post-Op Mobilization & DVT Shield: Mechanical intermittent pneumatic compression boots starting in the operating room, low-molecular-weight heparin (Enoxaparin) tailored to anti-Xa levels, electro-acupuncture at ST36 (Zusanli) and PC6 (Neiguan) to prevent post-operative nausea and paralytic ileus, and assisted bedside walking within 6 to 12 hours of surgery.
Country-by-Country Medical Travel, Ministry of Health (MOH) Sponsorship & Aviation Logistics Handbook
Each Middle Eastern nation operates distinct overseas treatment committee regulations, national carrier MEDIF aviation clearance procedures, consular legalization rules for living-donor organ/stem-cell kinship, and banking/insurance workflows. Below is our dedicated operational handbook for patients and medical coordinators across nine Middle Eastern countries.
Departure Hubs & Non-Stop Flights: King Khalid International Airport (Riyadh RUH), King Abdulaziz International Airport (Jeddah JED), and King Fahd International Airport (Dammam DMM). Direct non-stop flights operate daily to Beijing (PEK/PKX), Shanghai (PVG), Guangzhou (CAN), and Shenzhen (SZX) via Saudia (Saudi Arabian Airlines), Air China, China Southern, and China Eastern. Saudia's Medical Services Department in Jeddah and Riyadh processes MEDIF stretcher and onboard therapeutic oxygen requests within 48 hours.
MOH High Medical Committee & Insurance: For Saudi citizens applying for Royal Court Medical Orders or Ministry of Health (MOH) High Medical Committee overseas referral, our Chinese partner hospitals issue official bilingual Clinical Justification & Cost Proposals demonstrating why advanced therapies—such as Dual CD19/CD22 or BCMA CAR-T, Carbon Heavy-Ion Radiotherapy, or ALPPS liver surgery—provide superior curative potential. Private policies under Bupa Arabia, Tawuniya, and Medgulf are coordinated through our International Direct Billing Desk.
Departure Hubs & Non-Stop Flights: Dubai International (DXB) and Zayed International Airport Abu Dhabi (AUH). Emirates and Etihad Airways operate multiple daily widebody A380 and B777/B787 flights to Beijing, Shanghai, Guangzhou, Shenzhen, and Hangzhou. Both carriers support full ICU stretcher installations in Economy and high-flow medical oxygen in First and Business Class suites.
DOH Abu Dhabi (Thiqa), DHA Dubai & Private GOP: Emirati nationals holding Thiqa / Daman or referred by the Department of Health (DOH) Abu Dhabi International Patient Care (IPC) division and Dubai Health Authority (DHA) Overseas Treatment Office receive full pre-arrival medical board documentation, ICD-10-AM coding, and direct Embassy Medical Attaché progress reports every 7 days during hospitalization. Expatriates in the UAE insured by Cigna, Bupa Global, Sukoon, Allianz, or NEXTCARE receive 48-hour GOP pre-authorization.
Departure Hub & Non-Stop Flights: Hamad International Airport (Doha DOH). Qatar Airways, China Southern, and Xiamen Airlines provide non-stop connections to Beijing, Shanghai, Guangzhou, Hangzhou, and Chongqing. Qatar Airways' Qsuite Business Class offers fully enclosed private double suites ideal for semi-ambulatory oncology and post-surgical patients traveling with a family companion or flight nurse.
MOPH Treatment Abroad & QLM Insurance: Our liaison desk works closely with families applying to the Qatar Ministry of Public Health (MOPH) Medical Relations and Treatment Abroad Department and Hamad Medical Corporation (HMC) tumor boards, as well as Qatari citizens and residents covered by QLM Life & Medical Insurance and AlKhaleej Takaful.
Departure Hub & Flight Corridor: Kuwait International Airport (KWI). Kuwait Airways operates direct flights to Guangzhou Baiyun International Airport (CAN)—just 20 minutes from Sun Yat-sen University Cancer Center and Nanfang Hospital—while one-stop connections via Dubai or Doha reach Shanghai and Beijing in under 10 hours.
Kuwait MOH Overseas Treatment Office & GIG Gulf: Kuwaiti citizens enjoy 30-day visa-free access to China. For patients sponsored by the Kuwait Ministry of Health Overseas Treatment Department, Ministry of Defense, or Kuwait Oil Company (KOC) Ahmadi Hospital, we provide certified Arabic/English medical committee dossiers, itemized invoices, and authenticated discharge summaries.
Departure Hub & Clinical Priorities: Muscat International Airport (MCT). Omani citizens benefit from 30-day visa-free entry into China. Because inherited hemoglobinopathies (Beta-Thalassemia Major and Sickle Cell Disease) and complex orthopedic/oncology conditions are common referral needs from Muscat, Salalah, and Sohar, our pediatric hematology centers in Guangzhou (Nanfang Hospital) and Beijing (PKU People's Hospital) maintain a dedicated Omani family coordinator who handles HLA typing via couriered buccal swabs before the family even departs Muscat.
Direct Gulf Air Corridor to Shanghai & Guangzhou: Bahrain International Airport (BAH) is directly linked to both Shanghai Pudong (PVG) and Guangzhou (CAN) via non-stop Gulf Air Boeing 787 Dreamliner flights. Combined with 30-day visa-free entry for Bahraini passport holders, patients in Manama can board an evening Gulf Air flight and be admitted into Ruijin Hospital, Zhongshan Hospital, or SPHIC in Shanghai the very next afternoon for diabetic limb-salvage, robotic oncology surgery, or CAR-T therapy.
Consular Fast-Track & Oncology Collaboration: For patients in Amman referred following initial care at local oncology centers who require advanced therapies not yet available in the Levant—such as Solid-Tumor Claudin18.2/GPC3 CAR-T, Carbon Heavy-Ion Radiotherapy for skull-base chordoma, or Awake Glioma Craniotomy at Beijing Tiantan Hospital—our Government Liaison Desk issues official Municipal Foreign Affairs & Tertiary Hospital Visa Invitation Letters within 24 hours for 48-hour express S2 Medical Visa issuance at the Chinese Embassy in Amman.
Direct EgyptAir Flights to 4 Chinese Medical Hubs: Cairo International Airport (CAI) enjoys non-stop EgyptAir flights to Beijing (PEK), Shanghai (PVG), Guangzhou (CAN), and Hangzhou (HGH). This makes China uniquely accessible for Egyptian patients seeking ALPPS two-stage liver surgery, HAIC + Y-90 conversion therapy for hepatocellular carcinoma, living-related liver care at Renji Hospital, and CAR-T cellular immunotherapy. Express medical visas are processed through the Chinese Embassy in Cairo within 2 working days.
Direct Baghdad–Guangzhou/Beijing Flights & Pediatric/Complex Care: Iraqi Airways operates direct flights from Baghdad (BGW) to Guangzhou (CAN) and Beijing, while Emirates and Qatar Airways connect Erbil (EBL) and Basra (BSR). We assist Iraqi families with rapid embassy invitation letters in Baghdad and Erbil Consulate for pediatric retinoblastoma eye-salvage, thalassemia stem-cell cures, complex orthopedic 3D reconstruction, and oncology surgery.
Molecular Mechanisms of Standardized Halal Botanical Formulations & Clinical Acupuncture Protocols
Every botanical formula prescribed at our National TCM Clinical Research Centers (Guang'anmen, Xiyuan, Longhua, Shuguang, and Tianjin TCM) undergoes high-performance liquid chromatography (HPLC) active-compound fingerprinting, heavy-metal/pesticide clearance, and strict Halal verification (100% plant/mineral origin). Below are twelve clinically validated integrative regimens frequently prescribed for Middle Eastern patients.
| Standardized TCM Protocol / Formula | Core Halal Botanical Constituents | Validated Pharmacological & Molecular Mechanism | Primary Clinical Indication for GCC Patients |
|---|---|---|---|
| 1. Shenqi Fuzheng & Spore Oil Oncology Immune Protocol | Radix Astragali (Huangqi), Codonopsis (Dangshen), Ganoderma lucidum Triterpene Spore Oil, Ginsenoside Rg3 | Upregulates bone marrow granulocyte-macrophage colony-stimulating factor (GM-CSF), restores CD4+/CD8+ T-cell ratios and NK-cell perforin expression, and inhibits VEGF-mediated tumor neo-angiogenesis. | Prevents chemotherapy-induced neutropenia/fatigue; enhances PD-1 immunotherapy and post-CAR-T immune reconstitution. |
| 2. PHY906 (Huangqin Tang) GI Mucositis & Enteritis Shield | Scutellaria baicalensis (Huangqin), Paeonia lactiflora (Baishao), Glycyrrhiza uralensis, Ziziphus jujuba | Inhibits intestinal bacterial beta-glucuronidase, blocks NF-κB and COX-2 inflammatory cascades, and activates Lgr5+ intestinal crypt stem-cell regeneration (validated in Yale/NCI clinical trials). | Eliminates severe diarrhea, oral ulcers, and radiation enteritis during Irinotecan/FOLFIRINOX chemotherapy or pelvic radiotherapy. |
| 3. "Xing Nao Kai Qiao" Neuro-Plasticity & Buyang Huanwu Regimen | Astragalus, Angelica sinensis, Ligusticum chuanxiong, Carthamus tinctorius, Salvia miltiorrhiza + Scalp Electro-Acupuncture | Promotes brain-derived neurotrophic factor (BDNF) and VEGF expression in the ischemic penumbra, improves cerebral collateral microcirculation, and re-establishes corticospinal tract synaptic connectivity. | Post-ischemic/hemorrhagic stroke hemiplegia, motor aphasia, pseudobulbar dysphagia, and traumatic brain injury rehabilitation. |
| 4. Tangshen Formula & Bailing Renal Anti-Fibrotic Regimen | Astragalus, Rehmannia, Rheum officinale (prepared), Cornus officinalis, Cordyceps sinensis (fermented mycelium) | Downregulates transforming growth factor-beta 1 (TGF-β1)/Smad3 renal tubulointerstitial fibrosis pathway, protects glomerular podocytes from oxidative stress, and increases renal plasma flow. | Diabetic Nephropathy (Stage 3–4 CKD), persistent proteinuria, and elevated serum creatinine/BUN stabilization to delay dialysis. |
| 5. Huanglian Jiedu & Tianma Gouteng Metabolic-Vascular Protocol | Coptis chinensis (Berberine), Gastrodia elata, Uncaria rhynchophylla, Pueraria lobata, Crataegus | Activates hepatic AMPK insulin-sensitizing signaling, upregulates LDL-receptor expression (natural PCSK9 modulation), remodels gut Akkermansia muciniphila flora, and stabilizes carotid endothelial nitric oxide. | Type 2 Diabetes insulin resistance, metabolic fatty liver (MASLD/NASH), resistant hypertension, and microvascular angina. |
| 6. Duhuo Jisheng & Acupotomy Spine/Joint Decompression Protocol | Angelica pubescens, Eucommia ulmoides, Achyranthes bidentata, Gentiana macrophylla, Boswellia/Myrrh | Suppresses synovial IL-1β, TNF-α, and matrix metalloproteinase (MMP-13) cartilage degradation while ultrasound-guided acupotomy releases calcified ligamentum flavum and facet joint contractures. | Non-surgical management of lumbar disc herniation, spinal stenosis, sciatica, knee osteoarthritis, and rheumatoid/ankylosing spondylitis. |
| 7. Huangqi Guizhi Wuwu Peripheral Neuropathy Protocol | Astragalus membranaceus, Cinnamomum cassia, Paeonia lactiflora, Zingiber officinale, Spatholobus suberectus | Stimulates Schwann cell nerve growth factor (NGF) secretion, repairs dorsal root ganglion mitochondrial axonal transport, and improves vasa nervorum microperfusion via warm herbal foot/hand hydrotherapy. | Diabetic peripheral neuropathy (burning/numbness in feet) and chemotherapy-induced peripheral neuropathy (CIPN from Paclitaxel/Oxaliplatin/Bortezomib). |
| 8. Fuzheng Huayu Hepatic Anti-Cirrhosis Botanical Protocol | Salvia miltiorrhiza (Danshen), Schisandra chinensis, Semen Persicae, Gynostemma pentaphyllum | Inhibits hepatic stellate cell (HSC) activation, promotes collagenase-mediated degradation of septal extracellular matrix, and reduces portal venous pressure (FDA Phase II/III investigated). | Reversal of Stage F2–F3 hepatic fibrosis and early compensated cirrhosis following hepatitis B/C eradication or metabolic steatohepatitis. |
Additional Verified Case Summaries Across Rare Oncology, Pediatric Cardiac, Neuro-Robotics & Bariatric Care
Supplementing our primary patient testimonials in Section 11, these 12 clinical case abstracts illustrate the breadth of complex interventions completed for patients from across the Arabian Peninsula, Levant, and North Africa.
Patient & Protocol: 14-year-old boy with cortical T-ALL refractory to Nelarabine and Hyper-CVAD. Treated at Peking University People's Hospital (Beijing) with Donor-Derived Fratricide-Resistant CD7 CAR-T Therapy, achieving MRD-negative remission on Day 21, followed by haploidentical stem cell transplantation from his brother. Currently 16 months leukemia-free and back in school in Madinah.
Patient & Protocol: 68-year-old retired diplomat with 11-year levodopa-induced dyskinesia and freezing of gait. Underwent Remebot Robotic Bilateral Subthalamic Nucleus (STN) Rechargeable Deep Brain Stimulation at Huashan Hospital (Shanghai). UPDRS-III motor score improved by 74%; neurostimulator voltage is adjusted remotely via 5G tele-programming while he lives in Al Ain.
Patient & Protocol: 47-year-old woman with a recurrent petroclival meningioma encasing the internal carotid artery. Treated at Shanghai Proton & Heavy Ion Center (SPHIC) with 18 fractions of intensity-modulated Carbon Heavy-Ion + Proton raster-scanning radiotherapy. Zero cranial nerve palsy, complete tumor growth arrest, and preservation of 20/20 vision at 2-year follow-up.
Patient & Protocol: 39-year-old male (BMI 44.5 kg/m², HbA1c 9.8% on 90 units/day insulin). Underwent Da Vinci Robotic Single-Anastomosis Gastric Bypass (OAGB) + metabolic TCM microbiome reset at Ruijin Hospital (Shanghai). Discharged on Day 4; lost 42 kg over 7 months and achieved complete insulin-free diabetes remission (HbA1c 5.4%).
Patient & Protocol: 4-month-old infant with complex Transposition of the Great Arteries, ventricular septal defect, and left ventricular outflow tract obstruction. Transferred via commercial business class with flight neonatologist to Fuwai Hospital (Beijing) for a Nikaidoh Aortic Translocation & Biventricular Repair. Discharged in 11 days with normal oxygen saturation (99%).
Patient & Protocol: 63-year-old mother unable to climb stairs or pray comfortably due to Stage IV varus knee osteoarthritis. Underwent Simultaneous Bilateral Mako SmartRobotics™ Kinematic-Aligned Total Knee Replacement at Beijing Jishuitan / Shanghai Sixth People's Hospital. Stood bedside 5 hours post-op and achieved 130° deep knee flexion within 4 weeks.
Patient & Protocol: 52-year-old male with locally recurrent EBV-positive skull-base nasopharyngeal carcinoma after prior IMRT. Treated at Sun Yat-sen University Cancer Center (Guangzhou) with Endoscopic Transnasal Internal Carotid Artery Skeletonization Resection + Toripalimab (PD-1) + Gemcitabine, achieving complete plasma EBV-DNA clearance (0 copies/mL).
Patient & Protocol: 48-year-old engineer with cT3N1 rectal adenocarcinoma 2.4 cm from the anal verge, told locally he required permanent abdominoperineal colostomy. Underwent Total Neoadjuvant Therapy followed by Da Vinci Xi Robotic Intersphincteric Resection (ISR) & Transanal NOSES at CAMS Cancer Hospital (Beijing)—achieving R0 pathological complete response with zero abdominal specimen incision and preserved anal continence.
Patient & Protocol: 27-year-old male with C6 incomplete tetraplegia following a motor vehicle collision. Completed 8 weeks of intensive inpatient rehabilitation at Beijing Bo'ai Hospital (China Rehabilitation Research Center) & Guang'anmen TCM using TINAVI spinal decompression, epidural electrical stimulation, Fourier upper/lower-limb exoskeleton robotics, and electro-acupuncture—regaining independent hand grip and assisted walking.
Patient & Protocol: 36-year-old female with diffuse cutaneous systemic sclerosis and progressive interstitial lung fibrosis (FVC 58%). Received Targeted CD19 CAR-T Deep B-Cell Reset Therapy at Renji Hospital (Shanghai). Modified Rodnan Skin Score improved by 62%, anti-Scl-70 autoantibodies seroconverted negative, and lung FVC improved to 76% off mycophenolate.
Patient & Protocol: 79-year-old patriarch with severe right heart failure, ascites, and prior CABG (EuroSCORE II >18%, prohibitive for open re-sternotomy). Treated at Zhongshan Hospital (Shanghai) with the Chinese-invented LuX-Valve Plus Transjugular Orthotopic Tricuspid Valve Replacement on a beating heart. Discharged on Day 5 with complete resolution of leg edema and ascites.
Patient & Protocol: 44-year-old businesswoman diagnosed with a 1.6 cm intramucosal gastric body signet-ring cell carcinoma during our Painless Magnifying NBI Gastroscopy checkup in Shanghai. Instead of surgical gastrectomy, Professor Zhou's team at Zhongshan Endoscopy Center performed curative Endoscopic Submucosal Dissection (ESD) in 45 minutes—preserving 100% of her stomach with zero external incisions.
Complete Cross-Border Medical FAQ Encyclopedia (Clinical, Financial, Visa & Halal Logistics)
Q1: How quickly can an urgent cancer or cardiac patient from Saudi Arabia, UAE, Qatar, or Kuwait be admitted to a top hospital in Beijing or Shanghai?
Because citizens of Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain enjoy 30-day visa-free entry into China, there is zero embassy waiting time for ordinary passport holders. Once you send your medical reports via WhatsApp (+86 180 7951 9899), our professor-level Tele-MDT consultation is completed within 24 to 48 hours, and a VIP inpatient bed in the International Medical Wing (IMS) is reserved prior to takeoff. Patients can be admitted directly from the airport to their hospital suite within 48 to 72 hours of first contacting us.
Q2: Why is CAR-T Cell Therapy in China 70%–80% less expensive than in the United States or Europe, and is the quality identical?
In the United States, commercial CAR-T list prices ($475,000–$555,000 USD for the cells alone, plus $150,000–$250,000 USD for ICU/hospitalization) reflect Western biopharma pricing models and hospital markups. In China, domestic GMP viral vector manufacturing, automated closed-system cell bioreactors, and National Health Commission regulated tertiary hospital inpatient tariffs allow NMPA-approved commercial CAR-T therapies (including Carvykti®, Carteyva®, YiKaiDa®, and Fucaso®) to be delivered for $140,000–$165,000 USD all-inclusive, and hospital Investigator-Initiated Dual-Target CAR-T programs for $48,000–$85,000 USD. In fact, Carvykti® (Ciltacabtagene autoleucel)—widely regarded as the global gold standard BCMA CAR-T for Multiple Myeloma in the US and Europe—was originally invented and clinically developed in China (by Legend Biotech at Ruijin and Xi'an affiliated centers).
Q3: What happens if my treatment in China (such as CAR-T, Proton Therapy, or Stem Cell Transplant) takes longer than the 30-day visa-free period?
You have two seamless options: (1) Before departure, our hospital issues an official S2 Medical Visa Invitation Letter allowing a 90-to-180-day multi-entry visa; or (2) If you enter China immediately using your 30-day GCC visa-free privilege to avoid any delay, our legal and hospital foreign affairs team takes your passport and Hospital Admission Certificate to the local Exit-Entry Administration Bureau (PSB) VIP window in Beijing, Shanghai, Guangzhou, or Hangzhou to issue an In-Country Medical Stay Permit / Visa Extension for up to 180 days (covering both the patient and up to 3–5 accompanying family members) without leaving the hospital.
Q4: How are language barriers handled during doctor rounds, surgery consent, awake brain mapping, and 24-hour nursing care?
Every Middle Eastern patient is assigned a dedicated certified native Arabic & English medical interpreter with clinical training. Your interpreter accompanies you during all professor consultations, diagnostic scans, pre-operative anesthesia briefings, and daily ward rounds. All informed consent forms, surgical plans, pathology reports, and final discharge summaries are provided in written English and Arabic. In addition, senior department directors at PUMCH, Ruijin, Zhongshan, Huashan, Fuwai, and Tiantan completed clinical fellowships at Harvard, Mayo Clinic, Johns Hopkins, Memorial Sloan Kettering, or Heidelberg and communicate fluently in medical English.
Q5: Are Halal food, female privacy, and Islamic prayer needs strictly respected inside Chinese hospitals?
Yes—100%. China has a native Muslim population of over 25 million people with centuries-old Halal certification systems (China Islamic Association). All partner hospitals in Beijing, Shanghai, Guangzhou, Shenzhen, and Hangzhou provide certified Halal inpatient meals prepared in dedicated Halal kitchens, alongside delivery from upscale Arabic restaurants (Saudi, Emirati, Yemeni, Lebanese, and Turkish cuisine). Female patients from the Gulf are cared for by female nurses, female ultrasound/MRI technicians, and female Arabic interpreters, with privacy screens and "Women Only—Knock & Wait" door protocols on VIP suites.
Q6: What are the legal requirements for Living-Donor Liver, Kidney, or Bone Marrow Transplantation in China for international patients?
For Haploidentical Bone Marrow / Peripheral Blood Stem Cell Transplantation (HSCT)—which is a non-surgical blood apheresis collection similar to donating platelets—any biological parent, child, or sibling can donate immediately after HLA typing and infectious disease clearance. For Living-Donor Liver or Kidney Transplantation (such as a parent donating 20% of their left liver lobe to a child with biliary atresia at Renji Hospital), Chinese law and the Hospital Ethics Committee strictly require verified biological or spousal kinship supported by birth/family registry certificates authenticated by the Ministry of Foreign Affairs and the patient's Embassy in China. Commercial organ trade is strictly prohibited.
Q7: Can I bring 3 to 6 months of targeted cancer drugs or Halal TCM herbal granules back to Saudi Arabia, UAE, Qatar, or Kuwait?
Yes. Many newly approved targeted oncology drugs, antibody-drug conjugates (ADCs), bispecific antibodies, PD-1 inhibitors, and GMP-granulated TCM formulas in China cost 60%–80% less than in Western pharmacies. Upon discharge, our hospital pharmacy issues a Bilingual Official Medical Prescription, Customs Export Declaration, and Physician Letter of Personal Medical Necessity stamped by the Hospital International Wing, allowing patients to legally carry 3 to 6 months of personal medication through airport customs in China and the GCC.
Q8: How does post-treatment follow-up work once the patient returns home to the Middle East?
Before discharge, we establish a joint Sino-Gulf Continuity of Care Protocol. You receive all original DICOM imaging files (on encrypted USB and cloud link) plus a detailed bilingual follow-up schedule specifying exact blood tests and scans at Months 1, 3, 6, and 12. When you complete routine bloodwork or an MRI/PET-CT in Riyadh, Dubai, Doha, Kuwait, Muscat, Amman, or Cairo, you simply send the results to your case manager on WhatsApp (+86 180 7951 9899), and your Chinese chief physician reviews them and conducts a follow-up video consultation with you and your local doctor.
In-Depth Clinical Manuals: Staging, Pre-Flight Medical Stabilization, Inpatient Protocols & Long-Term Surveillance
To assist patients, family caregivers, and local attending physicians in Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Jordan, Egypt, and Iraq in preparing for cross-border treatment, our medical board has compiled twelve comprehensive specialty manuals detailing pre-travel medical optimization, exact diagnostic and surgical workflows in China, and post-return clinical monitoring.
Hematologic Malignancies: CAR-T vs. Bispecific Antibody vs. Allogeneic HSCT Clinical Decision Matrix
1. Pre-Departure Specimen & Washout Preparation: Before flying to Shanghai (Ruijin Hospital), Beijing (PKU People's Hospital), or Hangzhou (FAHZU) for CAR-T leukapheresis, patients should observe standardized medication washout windows so peripheral blood T-lymphocytes retain optimal proliferative fitness: systemic corticosteroids (dexamethasone/prednisone) must be tapered and stopped at least 72 hours prior to apheresis; lymphotoxic purine analogues (fludarabine, bendamustine, cladribine) should be avoided for 4 to 8 weeks prior to T-cell collection whenever clinically feasible; short-acting bridging agents (ibrutinib, zanubrutinib, lenalidomide, or low-dose polatuzumab) are held 3 to 5 days before leukapheresis.
2. Overcoming Antigen Escape with Dual-Target CAR-T: In Western single-target CD19 CAR-T trials, up to 30%–35% of relapses occur because lymphoma or leukemia blasts downregulate or mutate surface CD19 expression. Our partner centers perform quantitative flow cytometry and immunohistochemistry for CD19, CD20, CD22, CD7, CD30, BCMA, GPRC5D, and CS1 (SLAMF7) upon admission. If dim or heterogeneous CD19 expression is detected, patients receive Tandem Dual-Target CD19/CD22 or CD19/CD20 CAR-T (or Dual BCMA/GPRC5D CAR-T in Multiple Myeloma), blocking clonal antigen escape and elevating durable complete remission rates by 20% to 30%.
3. Post-Infusion Immunoglobulin & Antimicrobial Prophylaxis (Months 1 to 12): Because successful CD19 or BCMA CAR-T therapy also depletes normal B-cells and plasma cells (B-cell aplasia and hypogammaglobulinemia), patients returning to the Middle East follow a structured infection-shield protocol: Oral Acyclovir/Valacyclovir (for HSV/VZV prophylaxis) and Co-trimoxazole (TMP-SMX DS three times weekly for Pneumocystis jirovecii prophylaxis) for 6 to 12 months, plus monthly intravenous immunoglobulin (IVIG 400 mg/kg) whenever serum IgG falls below 4.0 g/L.
Obstructive Jaundice Biliary Decompression, Portal Vein Reconstruction & Post-Whipple Care
1. Managing Obstructive Jaundice Prior to Air Travel: Patients with pancreatic head adenocarcinoma, distal cholangiocarcinoma, or perihilar Klatskin tumors frequently present with severe obstructive jaundice (total bilirubin >250 µmol/L) and pruritus. If serum bilirubin exceeds 300 µmol/L with cholangitis (fever/chills), local endoscopic biliary drainage (ERCP plastic/metal stent) or percutaneous transhepatic cholangial drainage (PTCD) can be performed locally before flying, OR the patient can fly immediately to Shanghai/Beijing where our interventional radiology and ERCP teams perform ultrasound/fluoroscopy-guided biliary drainage within 6 hours of hospital arrival.
2. Quantitative Liver Reserve & 3D Holographic Surgical Simulation: Prior to major hepatectomy or ALPPS, every patient undergoes an Indocyanine Green 15-minute clearance test (ICG-R15) and 3D computer-assisted volumetric reconstruction mapping the exact territorial drainage of the middle, right, and left hepatic veins. In cirrhotic or post-chemotherapy livers, a Future Liver Remnant (FLR) of ≥40% is required; if FLR is 22%–38%, laparoscopic ALPPS Stage 1 or simultaneous portal vein + hepatic vein embolization (LVD) induces rapid compensatory hypertrophy within 10 to 14 days.
3. Long-Term Pancreatic Exocrine & Endocrine Optimization: Following radical Whipple or total pancreatectomy, patients receive enteric-coated pancrelipase microspheres (Creon 25,000–40,000 USP units with every main Halal meal and 10,000–20,000 units with snacks), fat-soluble vitamin supplementation (Vitamins A, D3, E, K, and B12), and continuous glucose monitoring to maintain optimal nutritional weight and muscle mass.
Multifocal Pulmonary Nodules, Tubeless Non-Intubated VATS & Molecular Adjuvant Therapy
1. Distinguishing Indolent vs. Invasive Ground-Glass Opacities (GGOs): High-resolution 1024-matrix thin-slice (0.5 mm) chest CT with AI three-dimensional consolidation-to-tumor ratio (CTR) analysis differentiates benign inflammatory nodules from atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma. For synchronous multifocal nodules across bilateral lungs, our thoracic surgeons combine Tubeless Single-Port 3D Anatomical Segmentectomy for the dominant lesion with Electromagnetic/Robotic Bronchoscopic Microwave Ablation (MWA) for secondary sub-centimeter nodules during a single anesthesia session—eradicating all lesions simultaneously while sparing lung parenchyma.
2. Inclusion Criteria & Safety of Tubeless Non-Intubated Thoracic Anesthesia: Patients with BMI <32 kg/m², ASA Grade I–III, and no severe airway hypersecretion undergo surgery under target-controlled propofol/remifentanil sedation with a laryngeal mask airway (LMA), thoracic paravertebral/intercostal block, and intrathoracic vagus nerve block (which completely abolishes the cough reflex during pulmonary hilum dissection). Because mechanical positive-pressure ventilation and neuromuscular paralytics are avoided, patients experience zero vocal cord injury, minimal systemic inflammatory cytokines, and rapid same-day recovery.
3. Precision Biomarker-Driven Neoadjuvant & Adjuvant Therapy: Resected lung tumors undergo immediate 1,021-gene NGS testing. Patients with Stage IB–IIIA EGFR-mutant NSCLC receive adjuvant Osimertinib/Aumolertinib (ADAURA protocol); ALK-positive patients receive Alectinib/Lorlatinib (ALINA protocol); and driver-negative PD-L1+ patients receive perioperative chemo-immunotherapy, achieving 5-year overall survival rates exceeding 85%.
Robotic McKeown Esophagectomy, D2+ Gastrectomy, HIPEC & Ultra-Low Anal Preservation
1. Minimally Invasive Robotic Esophagectomy with Three-Field Lymphadenectomy: For thoracic esophageal squamous cell carcinoma or gastroesophageal junction (Siewert Type I–III) adenocarcinoma, our thoracic and GI surgeons perform Da Vinci Xi Robotic McKeown or Ivor-Lewis Esophagectomy with meticulous bilateral recurrent laryngeal nerve lymph node dissection under continuous intraoperative nerve monitoring (reducing hoarseness risk to <3%) and tubular gastric conduit reconstruction.
2. Conversion Therapy for Gastric Cancer with Peritoneal Seeding (P1/CY1): Patients diagnosed with gastric adenocarcinoma and positive peritoneal washings or omental nodules undergo laparoscopic diagnostic staging followed by HIPEC (Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel/Cisplatin at 43°C) combined with systemic Zolbetuximab/Claudin18.2 antibody or Sintilimab/Nivolumab + SOX chemotherapy. In over 60% of responders, peritoneal cytology converts to negative, permitting curative conversion total or distal D2 gastrectomy.
3. Sphincter-Preserving Ultra-Low Rectal Surgery (ISR & NOSES): By combining Total Neoadjuvant Therapy (short-course radiation or long-course chemoradiation + consolidation CAPOX/immunotherapy) with robotic intersphincteric dissection down to the dentate line and transanal specimen extraction (NOSES), patients avoid a permanent abdominal stoma and undergo structured pelvic floor biofeedback training prior to returning home.
Brain Tumor Air-Travel Stabilization, Awake Craniotomy & Proton/Carbon-Ion Dosimetry
1. Safe Aviation Medicine Protocol for Brain Tumor & Hydrocephalus Patients: Commercial aircraft cabins are pressurized to an equivalent altitude of 6,000 to 8,000 feet (1,800–2,400 meters), which causes a 25%–30% expansion of trapped intracranial air (pneumocephalus) and mild hypoxia that can worsen peritumoral vasogenic brain edema. Before a patient with a large glioma, meningioma, brain metastasis, or skull-base chordoma flies from the Middle East to Beijing or Shanghai, our neurosurgical aviation team prescribes a tailored Pre-Flight Cerebral Edema & Seizure Shield (oral/IV Dexamethasone 4–8 mg q6–8h starting 48 hours pre-flight, Levetiracetam 500–1,000 mg BID, and supplemental onboard oxygen at 2–4 L/min if needed). For patients within 14 days of a recent craniotomy with residual intracranial air, we arrange sea-level cabin pressurization on an air ambulance jet.
2. Multimodal Intraoperative Navigation at Tiantan & Huashan Hospitals: Operating suites integrate 3.0T Intraoperative MRI (iMRI), 5-ALA (5-aminolevulinic acid) and Sodium Fluorescein tumor-glow fluorescence, Diffusion Tensor Imaging (DTI) pyramidal/arcuate fasciculus tractography, and 24-channel brain mapping. This allows neurosurgeons to resect 98%–100% of complex skull-base and eloquent-cortex tumors while preserving motor strength, vision, facial symmetry, and Arabic speech.
3. Carbon Heavy-Ion & Proton Radiotherapy Immobilization & Fractionation: At the Shanghai Proton and Heavy Ion Center (SPHIC), patients are fitted with a custom thermoplastic stereotactic mask and undergo 4D CT/MRI fusion simulation. Treatment typically consists of 16 to 22 daily 20-minute outpatient sessions over 3.5 to 4.5 weeks, with zero hair loss outside the micro-beam entry port and zero systemic nausea.
Aortic Dissection Transfer, Transcatheter Valve Replacement (TAVR/LuX-Valve) & LVAD Care
1. Hemodynamic Stabilization for Aortic Dissection & Aneurysm Patients: Patients traveling with subacute/chronic aortic dissection or large thoracic/abdominal aortic aneurysms are managed under strict anti-impulse therapy (target systolic blood pressure 100–120 mmHg and heart rate 55–65 bpm using oral beta-blockers such as metoprolol/bisoprolol and calcium channel blockers) with wheelchair/buggy airport assistance so the patient lifts zero luggage.
2. Pre-Procedural 4D Cardiac CT for Transcatheter Heart Valves: At Fuwai Hospital (Beijing) and Zhongshan Hospital (Shanghai), patients who are too frail or high-risk for open-heart surgery undergo ECG-gated 4D Cardiac CT and 3D transesophageal echocardiography (TEE). Using China's world-leading transcatheter valve portfolio—including VenusA-Plus / VitaFlow / TaurusElite retrievable TAVR valves (specifically engineered with higher radial force for heavily calcified bicuspid aortic valves), DragonFly / ValveClamp / MitraClip mitral repair, and the LuX-Valve Plus transjugular orthotopic tricuspid replacement system—procedures are completed in 60 to 90 minutes without cardiopulmonary bypass.
3. Destination Maglev Artificial Heart (LVAD) & Family Training: For end-stage heart failure patients receiving the 90-gram CorHeart 6 magnetically levitated Left Ventricular Assist Device, we provide bilingual Arabic/English controller and battery management training, dual international power adapters, and a 24/7 engineering tele-support hotline.
Remote HLA Buccal Swab Typing, Iron Chelation Preparation & Pediatric BMT Cabin Care
1. Zero-Travel Preliminary HLA Typing from the Middle East: Families in Saudi Arabia, UAE, Oman, Kuwait, Bahrain, Iraq, Jordan, and Egypt with a child suffering from Beta-Thalassemia Major, Sickle Cell Disease, Severe Aplastic Anemia, Primary Immunodeficiency, or Relapsed Leukemia do not need to fly the entire extended family to China just to find out who is the best donor. Either send local high-resolution HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 typing reports via WhatsApp, or we courier sterile buccal (cheek) swab kits to your home in the Gulf for 5-day NGS HLA typing and donor-specific antibody (DSA) screening.
2. Pre-Transplant Iron Overload & Hepatic Optimization in Thalassemia: Children over age 5 with transfusion-dependent thalassemia undergo cardiac and hepatic T2* MRI iron quantification upon arrival at Nanfang Hospital (Guangzhou) or PKU People's Hospital (Beijing). If serum ferritin exceeds 2,500 ng/mL or hepatomegaly is present, a 2-to-4-week pre-conditioning cytoreduction and intensive dual iron chelation + hydroxyurea/azacitidine protocol reduces Pesaro Class III risk to Class I/II, raising thalassemia-free survival above 97%.
3. Parent Rooming-In Inside Sterile Class-100 Laminar Cabins: Pediatric stem cell transplant cabins in our International Wings are specially designed so the child's mother or father can stay inside the sterile laminar-flow room 24/7 with the child throughout the 28-to-35-day engraftment period, eliminating separation anxiety.
Custom 3D-Printed Bone Prostheses, TINAVI Robotic Spine Surgery & Same-Day Joint Ambulation
1. 96-Hour Digital-to-Metal 3D Implant Engineering: For patients with pelvic chondrosarcoma, sacral chordoma, osteosarcoma, or complex revision hip/knee bone loss, thin-slice (0.625 mm) CT and 3.0T MRI DICOM files sent before departure allow our biomedical engineers at Peking University People's Hospital and Beijing Jishuitan Hospital to design and electron-beam-melt (EBM) a patient-specific porous titanium alloy (Ti6Al4V) implant with trabecular pore size of 600 microns (matching human cancellous bone elastic modulus) before the patient's pre-operative workup finishes.
2. Pediatric Growing-Rod & Adult Complex Scoliosis Correction: Children with early-onset osteogenesis imperfecta or congenital scoliosis receive magnetically controlled growing rods (lengthened non-invasively in clinic using an external magnet without repeat surgeries) or TINAVI robotic-navigated pedicle screw instrumentation with continuous somatosensory and motor evoked potential (SSEP/MEP) spinal cord monitoring.
Avoiding Below-Knee Amputation: Transverse Tibial Bone Transport, Pedal Loop Angioplasty & TCM
1. The Three-Pillar Limb-Salvage Protocol for Wagner Grade 3–4 Diabetic Ulcers: When a diabetic patient in the Gulf develops deep plantar abscess, osteomyelitis, or dry/wet toe gangrene with occluded anterior/posterior tibial and peroneal arteries, conventional vascular surgery often resorts to below-knee amputation. Our integrated limb-salvage teams at Shanghai Sixth People's Hospital, Beijing Guang'anmen Hospital, and FAHZU execute a three-pillar rescue protocol: (a) Retrograde Pedal-Plantar Loop Drug-Coated Balloon Angioplasty to restore macro-arterial inflow; (b) Ilizarov Transverse Tibial Cortex Transport (TTCT)—distracting a small 1.5 cm corticotomy window on the medial tibia by 1 mm/day for 14 days and then reversing it, which mobilizes bone-marrow endothelial progenitor cells and triggers dense neovascular capillary beds across the ischemic foot; and (c) Negative-Pressure Wound Therapy (VAC) + Antibiotic Bone Cement + Halal Shengji Yuhong Herbal Ointment for rapid epidermal regeneration.
2. Simultaneous Diabetic Nephropathy & Retinopathy Protection: Throughout the limb-salvage stay, integrative nephrologists and ophthalmologists manage fluid balance with low-contrast or CO2-guided angiography (protecting fragile kidneys from contrast nephropathy) and perform laser/anti-VEGF retinal stabilization.
Fudan TNBC Precision Subtyping, Scarless Endoscopic Mastectomy & LVA Lymphedema Cure
1. Triple-Negative & HER2-Low Breast Cancer Precision Therapy: At Fudan University Shanghai Cancer Center (FUSCC), every Triple-Negative Breast Cancer (TNBC) biopsy is classified into four molecular subtypes: Luminal Androgen Receptor (LAR), Immunomodulatory (IM), Basal-Like Immune-Suppressed (BLIS), and Mesenchymal-Like (MES). Combined with next-generation Antibody-Drug Conjugates (Trastuzumab deruxtecan DS-8201, Sacituzumab govitecan, or novel Chinese TROP2/HER3 ADCs) and PD-1 immunotherapy, pathological complete response (pCR) rates exceed 68%.
2. Supermicrosurgical Lymphaticovenular Anastomosis (LVA) & Vascularized Lymph Node Transfer (VLNT): For women suffering from chronic arm swelling after breast cancer or leg swelling after cervical/ovarian cancer lymphadenectomy, ICG near-infrared lymphography maps functional collecting lymphatics in real time. Under 40x–50x microscope magnification using 11-0 or 12-0 microsutures (finer than a human hair), 4 to 8 lymphaticovenular bypasses are created through 1.5 cm skin incisions, restoring physiological lymph drainage immediately.
Da Vinci SP Prostatectomy, Zero-Ischemia Hilar Kidney Tumor Salvage & 177Lu-PSMA Radioligands
1. Single-Port Extraperitoneal & Hood-Technique Robotic Prostatectomy: Using the Da Vinci SP or Xi system via an extraperitoneal Retzius-sparing approach (never entering the abdominal cavity, thereby avoiding bowel adhesions or ileus), urologists preserve the endopelvic fascia, puboprostatic collar, and neurovascular bundles. Intraoperative frozen-section margin analysis (NeuroSAFE) guarantees negative oncological margins while achieving >91% immediate urinary continence.
2. 177Lu-PSMA-617 & 225Ac-PSMA Targeted Radioligand Therapy: For patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after Enzalutamide/Abiraterone and Docetaxel, our nuclear medicine centers in Shanghai, Beijing, and Hainan Boao administer targeted beta- and alpha-emitting PSMA radioligand infusions guided by quantitative 68Ga-PSMA / 18F-FDG dual-tracer dosimetry.
Deep B-Cell & Plasma-Cell Immune Reset via CD19/BCMA CAR-T for Lupus, Scleroderma & Myasthenia
1. Patient Selection & Organ Recovery Potential: Candidates include patients with refractory Systemic Lupus Erythematosus (SLE with active Class III/IV/V Lupus Nephritis, thrombocytopenia, or CNS lupus), diffuse Systemic Sclerosis (Scleroderma with progressive skin thickening or interstitial lung disease), anti-MDA5/anti-synthetase dermatomyositis, ANCA-associated vasculitis, AQP4+ Neuromyelitis Optica Spectrum Disorder (NMOSD), and refractory Generalized Myasthenia Gravis who have failed ≥2 conventional immunosuppressants or biologics.
2. Clinical Course & Drug-Free Remission: All baseline immunosuppressants (mycophenolate, tacrolimus, azathioprine, cyclophosphamide) are discontinued prior to CAR-T infusion, and prednisone is tapered to ≤5–10 mg/day and then stopped completely. Following a single infusion of autologous or universal allogeneic CD19/BCMA CAR-T cells, deep tissue B-cell depletion lasts 90 to 120 days, after which newly reconstituted naive IgM+/IgD+ B-cells emerge completely free of pathogenic autoantibodies—achieving long-term, drug-free clinical remission in over 85% of treated patients.
Practical Step-by-Step Guidebook for Middle Eastern Families Traveling to China for Medical Care
Everything your family needs to know before departure and upon arrival in Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, or Hainan Boao—from packing medical records and binding Saudi/UAE/Qatari bank cards to mobile payment apps, to Halal dining, companion apartments, and customs clearance for take-home medications.
• Pathology Paraffin Blocks / Unstained Slides: If traveling for oncology surgery, CAR-T therapy, or a second-opinion tumor board, bring either the original formalin-fixed paraffin-embedded (FFPE) tissue block or 15 to 20 unstained positively charged glass slides (4–5 microns thick) plus H&E slides in your carry-on cabin bag (never check pathology slides in cargo hold luggage). This saves 4 to 5 days by avoiding a repeat biopsy upon arrival.
• DICOM Imaging Files: Bring your latest CT, MRI, and PET-CT scans on a CD/DVD or USB flash drive in standard DICOM (`.dcm`) format alongside printed English reports.
• Current Medications: Carry a 14-day supply of all regular cardiac, diabetic, antihypertensive, and pain medications in their original pharmacy boxes with prescriptions.
• Airport Tarmac / Gate Reception: Upon landing at Beijing (PEK/PKX), Shanghai Pudong (PVG), Guangzhou (CAN), Hangzhou (HGH), or Haikou/Boao, our bilingual coordinator meets you at the arrival gate with a signboard, assists with customs/immigration, and escorts you to a waiting Mercedes V-Class executive van or hospital ICU ambulance.
• 5G SIM & Unblocked Global Connectivity: We provide international roaming eSIMs and 5G pocket Wi-Fi routers upon arrival so your family's WhatsApp, FaceTime, Instagram, Snapchat, Gmail, and Gulf banking apps work seamlessly 24/7 without interruption.
• Seamless GCC Bank Card & Cash Use: International Hospital VIP cashiers accept Visa, Mastercard, Amex, UnionPay, and USD/SAR/AED wire transfers directly. Our concierge also helps you link your Saudi, Emirati, Qatari, or Kuwaiti Visa/Mastercard to the English version of Alipay in 3 minutes for effortless taxi, pharmacy, and shopping payments across China.
• Hospital Halal Meal Service & Arabic Catering: Inpatient suites receive three freshly cooked Halal meals daily tailored by clinical dietitians (low-sodium cardiac, diabetic glycemic-controlled, post-GI liquid/soft, or neutropenic sterile-cooked diets for CAR-T/BMT patients). For accompanying family members, we provide a curated Halal restaurant delivery app in Arabic/English featuring authentic Mandi, Kabsa, Shawarma, Grilled Kebabs, Fresh Hummus, and Lanzhou/Xinjiang Halal cuisine.
• Nearby Mosques & Prayer Spaces: Dedicated quiet prayer corners with Qibla direction and Wudu washing facilities are available in our VIP wings, and private chauffeur transport is provided for Friday Jummah prayers at historic mosques in Beijing, Shanghai, Guangzhou, and Hangzhou.
• IATA Fit-to-Fly Medical Certificate: 48 hours prior to your return flight to the Middle East, your attending professor and our aviation medicine physician issue an official IATA Fit-to-Fly clearance and arrange airport wheelchair or lounge priority boarding.
• Cold-Chain Biologics & Herbal Export Kit: If your ongoing care includes refrigerated targeted biologics (2°C–8°C), PD-1 antibodies, or 3–6 months of vacuum-sealed Halal TCM herbal granules, our hospital pharmacy provides an airline-approved 72-hour medical phase-change cooling travel case alongside a stamped Bilingual Customs Medical Export & Import Certificate for smooth passage through Gulf customs.
Day-by-Day Clinical Roadmaps: Exactly What Happens From Airport Arrival to Discharge
When planning cross-border medical travel from the Arabian Gulf, families and sponsoring ministries require clear, predictable timelines for flight bookings, companion leave, and visa validity. Below are the standardized day-by-day clinical schedules across our six most requested cross-border programs.
Hour-by-Hour Royal Diamond Whole-Body Screening Itinerary
Day 0 (Evening Arrival): Direct flight lands in Shanghai (PVG) or Beijing (PEK/PKX). VIP arrival gate reception, private Mercedes V-Class transfer to hospital VIP International Suite or adjacent 5-star hotel. Light low-residue Halal dinner; midnight fasting begins.
Day 1 (Fasting Imaging & Molecular Bloodwork): 07:30 AM bedside 120-biomarker blood draw, ctDNA 50-cancer methylation liquid biopsy, whole-exome/pharmacogenomic swab, and 13C-urea breath test. 08:30 AM Total-Body uEXPLORER low-dose PET-CT (or Whole-Body MRI) + Photon-Counting 640-Slice Coronary CT Angiography (CCTA). 10:30 AM freshly prepared Halal breakfast in private suite. 01:30 PM 3.0T/5.0T High-Resolution Brain MRI/MRA, 3D Echocardiography, Carotid Plaque Ultrasound, Thyroid/Abdominal/Pelvic Ultrasound, FibroScan Liver Elastography, and EOS 3D Full-Spine Scan. Evening bowel preparation in private suite.
Day 2 (Painless Endoscopy & Specialist Consultations): 08:30 AM Propofol-sedated Optical Magnifying NBI Gastroscopy & Colonoscopy (or Robotic Magnetically Controlled Capsule Endoscopy) with immediate painless polypectomy if polyps are found. 11:00 AM Halal recovery lunch. 02:30 PM 90-minute Multidisciplinary Results Review with Chief Internist, Cardiologist, Oncologist, and National Master TCM Physician; delivery of customized Halal herbal longevity granules.
Day 3 (Departure or Sightseeing): Receive bound English/Arabic Executive Medical Dossier + encrypted DICOM USB drive; VIP transfer to airport for flight home.
14-Day Da Vinci Xi/SP, Tubeless VATS or Whipple Surgical Pathway
Day 1 (Direct Ward Admission): Airport ambulance/VIP van pickup directly to the International Medical Services (IMS) single-family suite (zero ER wait). Attending surgical professor and Arabic medical interpreter conduct bedside physical examination and review prior DICOM scans.
Days 2 – 3 (Rapid Pre-Operative Staging & MDT): 68Ga-FAPI/PSMA/FDG PET-CT, 3.0T organ-specific MRI, 3D CT vascular reconstruction, cardiopulmonary exercise/echocardiography clearance, and Anesthesiology ERAS prehabilitation consultation. Multidisciplinary Tumor Board (MDT) finalizes surgical plan; bilingual surgical consent signed.
Day 4 (Day of Robotic / Microsurgical Operation): Procedure performed by the Department Chairman in our hybrid/robotic operating theater (2.5 to 5 hours depending on organ) with real-time family updates via Arabic interpreter every 90 minutes. Post-anesthesia recovery in ICU or VIP High-Dependency Unit.
Days 5 – 9 (ERAS Inpatient Recovery & TCM Support): Opioid-sparing nerve block analgesia, bedside mobilization within 12–24 hours, electro-acupuncture to accelerate bowel motility, surgical drain removal, and Halal clinical nutrition.
Days 10 – 14 (Pathology & NGS Review + Fit-to-Fly): Final histopathological staging and 1,021-gene NGS report reviewed; surgical staples/sutures removed; IATA Fit-to-Fly clearance issued for return flight to the Gulf.
30-Day Vein-to-Vein Cellular Immunotherapy Inpatient Roadmap
Days 1 – 3 (Admission & Antigen Density Profiling): Admission to Hematology VIP Wing at Ruijin Hospital, PKU People's Hospital, or FAHZU. Bone marrow aspirate/biopsy or core tissue immunohistochemistry quantifies exact CD19, CD20, CD22, CD7, BCMA, GPRC5D, or Claudin18.2 target density; baseline PET-CT and cardiac/neurological clearance completed.
Day 4 (Peripheral Blood T-Cell Leukapheresis): 3.5-hour painless apheresis collection in VIP suite; T-cells dispatched immediately in cold-chain courier to ISO Class-5 GMP gene-engineering facility.
Days 5 – 15 (Cell Manufacturing & Bridging Therapy): While CAR-T cells undergo lentiviral transduction, expansion, and 14-point sterility/potency release testing (or 72-hour FasTCAR processing), patient rests in serviced apartment or receives gentle targeted bridging therapy if tumor burden is high.
Days 16 – 18 (Lymphodepleting Conditioning): 3-day intravenous Fludarabine + Cyclophosphamide conditioning regimen.
Day 20 (Day 0 CAR-T Infusion): Intravenous infusion of engineered CAR-T cells over 20 minutes.
Days 21 – 33 (Day +1 to +13 Cytokine & Expansion Monitoring): Daily flow-cytometric CAR-T copy tracking and IL-6/CRP/ferritin checks with immediate bedside Tocilizumab/Siltuximab shield.
Day 34 (Day +14 to +28 Remission Verification): Bone marrow MRD flow cytometry (10⁻⁵–10⁻⁶) and whole-body PET-CT confirm Complete Remission prior to discharge home.
Shanghai Proton & Heavy Ion Center (SPHIC) Outpatient/VIP Schedule
Days 1 – 2 (MDT Evaluation & Immobilization Mold): Consultation with SPHIC Chief Radiation Oncologist; fabrication of custom sub-millimeter thermoplastic head/neck or body vacuum immobilization cradle; 4D respiratory-gated CT and 3.0T MRI simulation.
Days 3 – 7 (Monte Carlo Bragg-Peak Physics Planning): Medical physicists calculate pencil-beam raster-scanning Carbon-Ion (12C6+) and Proton dose distributions, verifying organs-at-risk (brainstem, optic chiasm, spinal cord, GI tract) constraints on patient-specific phantoms.
Days 8 – 28 (12 to 20 Daily Particle Beam Sessions): Monday-through-Friday daily 20-minute non-invasive particle irradiation sessions. Because carbon heavy ions cause zero systemic pain or surgical wounds, patients spend the rest of each day relaxing in their luxury hotel or serviced apartment in Pudong Shanghai.
Days 29 – 30 (End-of-Treatment MRI & Discharge): Post-therapy MRI, bilingual dosimetry summary, and return flight to the Middle East.
"Beijing Protocol" Haploidentical Stem Cell Transplant Schedule
Days 1 – 7 (Recipient & Family Donor Workup): Confirmatory high-resolution HLA typing, DSA antibody check, cardiac/hepatic T2* MRI iron quantification, dental/ENT infection clearance, and Hickman/PICC central line placement.
Days 8 – 16 (Myeloablative Conditioning in Class-100 Sterile Cabin): Patient enters positive-pressure HEPA laminar-flow cabin (with 1 parent rooming-in for pediatric cases); pharmacokinetic-guided Busulfan/Fludarabine/Cyclophosphamide/ATG conditioning administered; donor receives 5 days of subcutaneous G-CSF mobilization.
Days 17 – 18 (Day 01 & 02 Stem Cell Infusion): Donor stem cells collected via peripheral apheresis and infused fresh into the recipient.
Days 19 – 32 (Neutrophil & Platelet Engraftment): White blood cells and platelets engraft between Day +11 and Day +15; chimerism PCR confirms >99% donor hematopoiesis.
Days 33 – 60 (Immune Stabilization & Outpatient Observation): Step-down from sterile cabin to VIP ward and nearby serviced apartment for weekly CMV/EBV PCR and cyclosporine/tacrolimus trough monitoring before flying home cured and transfusion-free.
Intensive Post-Stroke, Spinal Cord & Chronic Disease Inpatient Schedule
Days 1 – 2 (Integrative Neurological & TCM Constitutional Assessment): Functional Independence Measure (FIM), Fugl-Meyer motor scale, videofluoroscopic swallowing study, 3.0T DTI brain tractography, and four-pillar TCM pulse/tongue diagnosis.
Days 3 – 21+ (Daily 6-Modality Intensive Rehabilitation):
• 08:30 AM: "Xing Nao Kai Qiao" scalp & meridian electro-acupuncture (45 mins).
• 09:30 AM: Brain-Computer Interface (BCI) upper-limb & lower-limb robotic exoskeleton gait training (60 mins).
• 11:00 AM: Repetitive Transcranial Magnetic Stimulation (rTMS) + speech/swallowing neuromuscular electrical stimulation.
• 02:00 PM: Hyperbaric Oxygen Therapy (HBOT at 2.0 ATA) to revitalize ischemic penumbra neurons.
• 03:30 PM: Medical Tuina orthopedic manipulation, warm moxibustion, and herbal hydrotherapy.
• Morning & Evening: Customized 100% Halal GMP botanical decoctions.
Final 2 Days: Re-evaluation showing measurable gains in limb strength, speech, and walking; 3-month supply of vacuum-sealed Halal herbal granules packed with customs clearance certificates.
2026 Cross-Border Medical Procedure Cost Transparency Directory (30 Major Procedures)
Official reference inpatient package ranges at Chinese Class-A Tertiary (San-Jia) & JCI International Wings compared against US, UK/German, and Singapore private hospital tariffs.
| Specialty & Procedure Name | China Top Tertiary / VIP Wing (USD) | United States (USD) | UK / Germany / Switzerland | Typical Inpatient Stay |
|---|---|---|---|---|
| 1. Commercial CD19 or BCMA CAR-T Therapy (Carteyva / Carvykti / Fucaso) | $140,000 – $165,000 | $495,000 – $680,000 | $380,000 – $480,000 | 21 – 28 Days |
| 2. Dual-Target CD19/CD22, CD7, or Solid-Tumor Claudin18.2/GPC3 CAR-T (IIT) | $48,000 – $88,000 | $450,000+ (If available) | $320,000+ | 21 – 28 Days |
| 3. Autoimmune Deep B-Cell Reset CAR-T (Refractory SLE Lupus / Scleroderma) | $52,000 – $78,000 | $450,000+ | $290,000+ | 18 – 24 Days |
| 4. Proton & Carbon Heavy-Ion Radiotherapy Full Course (SPHIC Shanghai) | $38,000 – $48,000 | $135,000 – $220,000 | $85,000 – $140,000 | 3 – 4 Weeks (Outpatient) |
| 5. Haploidentical Allogeneic Stem Cell Transplant ("Beijing Protocol" BMT) | $55,000 – $95,000 | $380,000 – $650,000 | $240,000 – $380,000 | 45 – 65 Days |
| 6. Pediatric Living-Related Liver Care (Biliary Atresia / Metabolic) | $48,000 – $68,000 | $450,000 – $750,000 | $260,000 – $390,000 | 28 – 35 Days |
| 7. Radical Pancreaticoduodenectomy (Whipple) with Vascular Reconstruction | $22,000 – $35,000 | $115,000 – $195,000 | $75,000 – $125,000 | 12 – 16 Days |
| 8. Anatomical Hepatectomy / Laparoscopic ALPPS Two-Stage Liver Resection | $18,000 – $34,000 | $110,000 – $180,000 | $70,000 – $115,000 | 10 – 18 Days |
| 9. Tubeless Non-Intubated Uniportal VATS Lung Segmentectomy / Lobectomy | $12,500 – $19,500 | $65,000 – $110,000 | $42,000 – $72,000 | 3 – 5 Days |
| 10. Da Vinci Xi / SP Robotic Nerve-Sparing Radical Prostatectomy | $15,500 – $24,000 | $68,000 – $125,000 | $45,000 – $78,000 | 6 – 8 Days |
| 11. Da Vinci / Toumai Robotic Sphincter-Saving Low Rectal Resection (ISR/NOSES) | $16,000 – $25,000 | $75,000 – $135,000 | $48,000 – $82,000 | 8 – 11 Days |
| 12. Total Aortic Arch Replacement + Frozen Elephant Trunk ("Sun's Procedure") | $28,000 – $44,000 | $160,000 – $290,000 | $95,000 – $165,000 | 12 – 15 Days |
| 13. Transcatheter Aortic / Mitral / Tricuspid Valve (TAVR / MitraClip / LuX-Valve) | $26,000 – $39,000 | $110,000 – $185,000 | $68,000 – $110,000 | 4 – 6 Days |
| 14. Off-Pump Total Arterial Coronary Bypass (CABG) / Hybrid Revascularization | $21,000 – $32,000 | $115,000 – $190,000 | $65,000 – $105,000 | 8 – 12 Days |
| 15. Awake Craniotomy / Skull-Base Microsurgery with Intraoperative 3.0T MRI | $19,500 – $34,000 | $120,000 – $210,000 | $72,000 – $125,000 | 10 – 14 Days |
| 16. Remebot Robotic Bilateral Deep Brain Stimulation (DBS Rechargeable System) | $24,000 – $36,000 | $95,000 – $155,000 | $62,000 – $98,000 | 7 – 10 Days |
| 17. Custom 3D-Printed Porous Titanium Pelvic / Vertebral Tumor Reconstruction | $22,000 – $35,000 | $140,000 – $240,000 | $85,000 – $145,000 | 12 – 16 Days |
| 18. Stryker Mako SmartRobotics™ Total Knee or Hip Replacement (Unilateral) | $10,500 – $14,500 | $48,000 – $78,000 | $28,000 – $45,000 | 5 – 7 Days |
| 19. Diabetic Foot Limb-Salvage (Transverse Tibial Bone Transport + Angioplasty) | $13,500 – $22,000 | $75,000 – $130,000 | $48,000 – $80,000 | 14 – 21 Days |
| 20. Supermicrosurgical Lymphaticovenular Anastomosis (LVA for Lymphedema) | $8,800 – $13,500 | $45,000 – $85,000 | $32,000 – $55,000 | 4 – 6 Days |
Advanced Salvage & Curative Pathways for Complex, Metastatic & Treatment-Refractory Conditions
Many Middle Eastern patients contact our referral desk after first- and second-line standard treatments in local or Western hospitals have been exhausted. Below is our clinical reference matrix for sixteen complex, rare, or metastatic conditions where China's national medical centers offer specialized surgical, cellular, particle-beam, or theranostic rescue protocols.
1. Peritoneal Carcinomatosis (Gastric, Colorectal, Ovarian, Appendiceal Pseudomyxoma)
Clinical Challenge: Peritoneal metastasis is historically treated as terminal because systemic intravenous chemotherapy penetrates the peritoneal-plasma barrier poorly.
China Tertiary Protocol (Beijing Aerospace Center Hospital / FUSCC / Ruijin / SYSUCC): Quantitative 68Ga-FAPI-04 PET-CT and diagnostic laparoscopy establish the Peritoneal Cancer Index (PCI). Patients undergo Complete Cytoreductive Surgery (CRS: peritonectomy + greater/lesser omentectomy + multivisceral resection) combined with High-Precision Closed/Open Hyperthermic Intraperitoneal Chemotherapy (HIPEC at 43.0°C ± 0.1°C) and bidirectional intraperitoneal paclitaxel/nab-paclitaxel infusion via subcutaneous peritoneal port. For Claudin18.2+ gastric peritoneal metastasis, sequential intraperitoneal and intravenous Claudin18.2 CAR-T (CT041) or Zolbetuximab/ADC therapy achieves high ascites clearance and durable survival.
2. Recurrent Head & Neck Cancer and EBV-Positive Nasopharyngeal Carcinoma (NPC)
Clinical Challenge: Tumoral recurrence inside a previously irradiated nasopharynx, paranasal sinus, or skull base carries a high risk of fatal internal carotid artery blowout if re-treated with conventional photon radiotherapy or open facial-translocation surgery.
China Tertiary Protocol (SYSUCC Guangzhou / Eye & ENT Hospital Fudan / SPHIC): Prior to salvage surgery, neuro-interventionalists perform a Balloon Occlusion Test (BOT) or place a covered stent / perform EC-IC bypass to protect the internal carotid artery, followed by Endoscopic Endonasal Internal Carotid Artery Skeletonization Nasopharyngectomy. Alternatively, Intensity-Modulated Carbon Heavy-Ion Re-Irradiation at SPHIC delivers ablative biological dose to the recurrent tumor while sparing the optic nerves, brainstem, and carotid wall—paired with EBV-specific CTL cellular immunotherapy or Toripalimab/Camrelizumab PD-1 blockade.
3. Retroperitoneal Liposarcoma, Leiomyosarcoma & Pelvic Bone Sarcomas
Clinical Challenge: Giant retroperitoneal sarcomas (often weighing 5 to 15 kg at recurrence) encase the abdominal aorta, inferior vena cava (IVC), iliac vessels, kidney, and psoas muscle.
China Tertiary Protocol (Zhongshan Hospital Retroperitoneal Sarcoma Center / PKU People's Hospital): Having performed over 4,000 retroperitoneal sarcoma resections, our multidisciplinary vascular and surgical oncology teams perform En-Bloc Compartmental Resection with Prosthetic Gore-Tex Replacement of the Abdominal Aorta and Inferior Vena Cava, combined with Ex-Vivo Renal Autotransplantation (removing the encased kidney, dissecting the sarcoma off the renal hilum under hypothermic bench perfusion, and re-implanting the healthy kidney into the iliac fossa).
4. Brainstem Glioma (DIPG / H3K27M-Mutant), Thalamic Glioma & Recurrent Glioblastoma
Clinical Challenge: Intrinsic pontine, medullary, and thalamic tumors are considered inoperable in most centers worldwide, and blood-brain barrier impermeability limits systemic chemotherapy.
China Tertiary Protocol (Beijing Tiantan Hospital Brainstem Ward / Huashan Hospital / Boao BNCT): Tiantan Hospital operates the world's largest dedicated Brainstem Neurosurgery Ward (performing 600+ brainstem microsurgeries annually using multimodal DTI tractography mapping of corticospinal and medial lemniscus safe entry zones). Post-resection or for diffuse H3K27M tumors, patients are evaluated for Intraventricular Ommaya Reservoir B7-H3 / GD2 / EGFRvIII / IL13Rα2 Locoregional CAR-T Cell Infusions, Tumor Treating Fields (TTFields), or single-session Boron Neutron Capture Therapy (BNCT).
5. Refractory Sickle Cell Disease & Beta-Thalassemia Major in Adolescents & Young Adults
Clinical Challenge: Older adolescents and young adults (aged 12–28) in the Arabian Gulf with transfusion-dependent Beta-Thalassemia Major or severe vaso-occlusive Sickle Cell Disease (stroke, acute chest syndrome, avascular hip necrosis) often have heavy hepatic/cardiac hemosiderosis and alloimmunization from hundreds of prior blood transfusions.
China Tertiary Protocol (Nanfang Hospital / PKU People's / Ruijin / CAMS Hematology Tianjin): Patients have two curative pathways: (1) Reduced-Toxicity TBF/ATG Haploidentical Allogeneic HSCT using a parent or half-matched sibling donor following a 3-week outpatient pre-transplant immune-suppression and iron-depletion phase; or (2) Autologous CRISPR/Cas9 or Base-Edited BCL11A Erythroid Enhancer Hematopoietic Stem Cell Gene Therapy (which reactivates fetal hemoglobin HbF to >40%–90% using the patient's own stem cells, with zero risk of Graft-Versus-Host Disease and no need for a family donor).
6. Neuroendocrine Neoplasms (Pancreatic & GI NETs with Diffuse Liver Metastases)
Clinical Challenge: Grade 1–3 Gastroenteropancreatic Neuroendocrine Tumors frequently present with bilobar hepatic metastases and debilitating carcinoid syndrome or insulinoma/gastrinoma hormone crises.
China Tertiary Protocol (FUSCC / Ruijin / PUMCH / Peking University Cancer Hospital): Dual-tracer 68Ga-DOTATATE and 18F-FDG PET-CT maps receptor heterogeneity. Surgical teams perform cytoreductive debulking of >90% of hepatic metastases combined with intraoperative microwave ablation, transarterial bland embolization (TAE), Surufatinib (China-developed dual VEGFR/FGFR1/CSF-1R inhibitor specifically approved for pancreatic and extrapancreatic NETs), and 177Lu-DOTATATE (Lutathera) Peptide Receptor Radionuclide Therapy (PRRT).
7. Complex Brachial Plexus Avulsion, Peripheral Nerve Injury & Microsurgical Hand Reconstruction
Clinical Challenge: Traumatic root avulsion of the brachial plexus (C5–T1) from motor vehicle accidents or birth palsy causes complete paralysis of the shoulder, elbow, and hand.
China Tertiary Protocol (Huashan Hospital Department of Hand Surgery — Academician Gu Yudong's Center): World pioneer of the Contralateral C7 (cC7) Nerve Root Cross-Transfer Procedure (published in the New England Journal of Medicine for both traumatic brachial plexus paralysis and central spastic arm paralysis after stroke/brain injury). Combined with free functioning gracilis muscle transfer, phrenic/accessory nerve neurotization, and intensive neuro-acupuncture, patients regain elbow flexion and functional hand grasp.
8. Inherited Retinal Dystrophies, Keratoprosthesis & Complex Ophthalmic Microsurgery
Clinical Challenge: End-stage corneal blindness (after multiple failed corneal grafts, chemical burns, or Stevens-Johnson syndrome), severe diabetic tractional retinal detachment, and inherited RPE65/ND4 Leber Hereditary Optic Neuropathy (LHON).
China Tertiary Protocol (Beijing Tongren Hospital / Zhongshan Ophthalmic Center Guangzhou / Eye & ENT Hospital Shanghai): Zhongshan Ophthalmic Center (ranked #1 in China, performing 100,000+ eye surgeries/year) and Tongren Hospital provide Boston Type I/II & MICOF Titanium Keratoprosthesis (Artificial Cornea) Implantation, 27-gauge ultra-high-speed vitreoretinal microsurgery, and rAAV2-ND4 Gene Therapy intravitreal injection for Leber Hereditary Optic Neuropathy.
The Sino-Gulf International Patient Rights, Financial Transparency & Cultural Dignity Charter
1. Direct Official Hospital Billing & Zero Hidden Markups
Every medical examination, surgical procedure, CAR-T cell infusion, pharmaceutical prescription, and VIP ward bed fee is billed at the official published International Medical Services (IMS) tariff of the respective Class-A Tertiary or JCI hospital. Patients, embassies, and insurance companies pay the hospital cashier or official hospital bank account directly, receiving stamped itemized bilingual receipts and tax invoices.
2. Honest Evidence-Based Triage (No False Promises)
Before we ever recommend that a patient board a flight from the Middle East to China, our Chinese chief physicians review the complete medical file. If a condition can be treated equally well in the patient's home country, or if a terminal patient is too fragile to benefit from international travel, our medical board states this candidly during the remote Tele-MDT consultation and provides supportive palliative or local treatment recommendations instead.
3. Islamic Cultural Dignity, Confidentiality & 24/7 Escort
All medical records, genetic data, and royal or family identities are protected under strict hospital confidentiality protocols. From airport tarmac arrival to inpatient nursing, Halal nutrition, prayer accommodation, and return flight boarding, no Middle Eastern patient or family member is ever left to navigate a hospital corridor alone.
Additional Verified Patient Reviews from Makkah, Khobar, Abu Dhabi, Doha, Kuwait, Muscat, Manama, Amman, Cairo & Baghdad
Every cross-border medical journey involves not only surgical and cellular mastery, but also compassionate family care, clear communication, and seamless post-discharge continuity. Below are twelve additional case accounts from Middle Eastern families treated across our Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, and Hainan Boao hospital hubs.
Patient: Hajj Abdulrahman Al-Harbi (Age 63) • Hospital: Beijing Tiantan Hospital / Huashan Hospital Shanghai
"My father lost peripheral vision in both eyes (bitemporal hemianopsia) from a 4.2 cm invasive pituitary adenoma compressing the optic chiasm and invading the bilateral cavernous sinuses. Using 4K 3D endoscopic endonasal transsphenoidal microsurgery with intraoperative Doppler carotid mapping and 3.0T intraoperative MRI, the neurosurgical team removed the entire tumor through his nostrils without a single external incision. Within 24 hours of waking up, his visual fields expanded dramatically, his hormonal axes stabilized without CSF leak, and we returned to Makkah 9 days later."
Patient: Mr. Fahad Al-Qahtani (Age 60) • Hospital: Ruijin Hospital Shanghai
"After my TP53-mutated Mantle Cell Lymphoma progressed through bendamustine-rituximab, ibrutinib, and venetoclax with massive splenomegaly, Ruijin Hospital's hematology team administered commercial Relmacabtagene autoleucel (Carteyva® CD19 CAR-T) combined with low-dose bridging acalabrutinib. By Day 28, my spleen returned to normal size and bone marrow minimal residual disease was negative at 10⁻⁶ sensitivity. Having a dedicated Saudi-dialect Arabic translator and Halal lamb kabsa delivered to my VIP room made five weeks in Shanghai feel like home."
Patient: Mr. Rashid Al-Suwaidi (Age 54) • Hospital: FUSCC Shanghai / PKU First Hospital Beijing
"Having lost my left kidney twenty years ago, discovering a 5.4 cm endophytic renal cell carcinoma deep inside the hilum of my only remaining right kidney was terrifying. Surgeons abroad warned that radical nephrectomy and lifelong hemodialysis were unavoidable. In Shanghai, using 3D holographic mixed-reality vascular printing and the Da Vinci Xi robot with super-selective tertiary renal artery branch clamping (zero global ischemia), the chief urologist enucleated the entire tumor with negative margins while preserving 84% of my solitary kidney. My post-op eGFR is 72 mL/min and I do not need dialysis."
Patient: Master Zayed Al-Mazrouei (Age 6) • Hospital: Shanghai Xinhua / Children's Hospital + TCM Rehab
"Our son Zayed had severe spastic diplegic cerebral palsy (GMFCS Level III) from premature birth and walked only on his tiptoes with scissoring legs. In Shanghai, he underwent single-level laminectomy Selective Dorsal Rhizotomy (SDR) guided by 32-channel intraoperative electromyography (cutting only the hyperactive sensory rootlets causing spasticity while preserving motor strength), followed by 4 weeks of intensive pediatric Tuina, warm herbal hydrotherapy, and robotic gait training. Today his heels touch the floor flatly and he walks independently across our living room in Abu Dhabi."
Patient: Mr. Jassim Al-Kuwari (Age 59) • Hospital: CAMS National Cancer Center Beijing / Zhongshan Shanghai
"Diagnosed with mid-thoracic esophageal squamous cell carcinoma causing dysphagia, I received two cycles of neoadjuvant Camrelizumab (PD-1) + nab-paclitaxel/carboplatin in China, which shrank the tumor by 80%, followed by a Da Vinci Xi Robotic McKeown Esophagectomy with continuous recurrent laryngeal nerve monitoring. My voice was 100% preserved, pathology showed complete tumor regression (ypT0N0M0), and I was swallowing soft Halal foods on Day 7."
Patient: Mrs. Noura Al-Enezi (Age 38) • Hospital: Tongji / Ruijin / Tiantan Neuro-Immunology Center
"Despite thymectomy, pyridostigmine, high-dose steroids, eculizumab, and frequent IVIG/plasmapheresis admissions in Kuwait, I suffered repeated myasthenic crises with bulbar weakness and ptosis. Receiving anti-BCMA CAR-T cell therapy in China eliminated the long-lived plasma cells producing anti-AChR antibodies. Within two months, my QMG clinical score dropped from 21 to 2, and I breathe, swallow, and care for my children without steroids or IVIG."
Patient: Mr. Hilal Al-Saidi (Age 35) • Hospital: Peking University People's / Third Hospital Beijing
"Advanced ankylosing spondylitis fused my thoracolumbar spine into a 95-degree chin-on-chest kyphotic deformity so I could only look at my feet when walking. Using 3D-printed vertebral osteotomy templates and the TINAVI spine robot under continuous multimodal spinal cord neuromonitoring, the Beijing spine team performed a two-level pedicle subtraction osteotomy (PSO), restoring my upright posture so I can look straight ahead at the horizon for the first time in twelve years."
Patient: Mr. Salman Al-Doseri (Age 50) • Hospital: Shanghai Proton & Heavy Ion Center (SPHIC)
"Facing enucleation of my left eye for a large choroidal melanoma near the optic disc, I flew Gulf Air direct from Bahrain to Shanghai. In just 5 daily fractions of Carbon Heavy-Ion pencil-beam radiotherapy with computerized eye-tracking fixation at SPHIC, the tumor was ablated completely while preserving my intact eye and useful vision."
Patient: Miss Aya Al-Zoubi (Age 10) • Hospital: Institute of Hematology CAMS / PKU People's Hospital
"Our daughter Aya had sudden-onset Very Severe Aplastic Anemia (neutrophils 0.05, platelets 4,000) with life-threatening mucosal bleeding. Using an emergency port/express medical visa, we reached Beijing within 72 hours. She underwent immediate haploidentical stem cell transplantation from her mother under the Beijing Protocol, engrafted on Day +11, and returned to Jordan with completely normal blood counts."
Patient: Mr. Tarek Abdel-Rahman (Age 69) • Hospital: Fuwai Hospital Beijing
"Ten years after a bioprosthetic mitral valve replacement in Cairo, the valve degenerated severely alongside three-vessel coronary artery disease. Because of dense mediastinal adhesions and reduced ejection fraction (34%), local surgeons declined a redo sternotomy. At Fuwai Hospital in Beijing, the cardiac team performed a minimally invasive transcatheter Valve-in-Valve mitral implantation combined with hybrid coronary stenting—avoiding open chest re-entry entirely."
Patient: Mrs.ajeeda Barzani (Age 52) • Hospital: FUSCC Shanghai / PUMCH Beijing
"Following incomplete debulking surgery locally for Stage IIIC high-grade serous ovarian cancer, 68Ga-FAPI PET-CT in Shanghai mapped residual diaphragmatic and mesenteric implants. The gynecological oncology team performed complete R0 cytoreductive surgery with closed-abdomen Cisplatin/Paclitaxel HIPEC, followed by HRD-guided Niraparib/Olaparib maintenance. Her CA125 remains 6.4 U/mL two years later."
Patient: Sheikh Nasser Al-Sudairi (Age 65) • Hospital: Guang'anmen / Xiyuan TCM Hospital Beijing
"My serum creatinine had risen steadily to 245 µmol/L (eGFR 24 mL/min) with 3.8 g/24h proteinuria despite SGLT2 inhibitors and ARB therapy. After a 21-day inpatient integrative nephrology program in Beijing combining Halal Tangshen/Astragalus botanical decoctions, renal acupoint iontophoresis, and low-protein clinical nutrition, my 24-hour urine protein dropped to 0.75 g and my creatinine improved to 158 µmol/L (eGFR 39), keeping me off dialysis for over two years."
Geriatric Perioperative Safety Shield for Elderly Patients (Aged 70–90+) with Diabetes, Cardiac Stents & Renal Insufficiency
In Middle Eastern families, honoring and protecting elderly parents and grandparents is paramount. Many senior patients traveling from the Gulf present with multiple overlapping comorbidities—such as long-standing Type 2 diabetes, prior coronary artery bypass or drug-eluting stents requiring dual antiplatelet therapy (Aspirin + Clopidogrel/Ticagrelor), atrial fibrillation on direct oral anticoagulants (Apixaban/Rivaroxaban), COPD, or Stage 3 chronic kidney disease.
1. Perioperative Antiplatelet & Anticoagulation Bridging
Instead of abruptly stopping cardiac stent medications (which risks perioperative stent thrombosis) or operating on full oral anticoagulants (which risks surgical bleeding), our cardiology and hematology teams perform platelet function testing (VerifyNow / TEG platelet mapping) and transition patients onto ultra-short-acting intravenous Cangrelor or Tirofiban and unfractionated/low-molecular-weight heparin bridging up until 4 to 6 hours before robotic surgery, resuming cardiac protection immediately once hemostasis is verified.
2. Post-Operative Delirium & Cognitive Preservation
Elderly patients placed in a foreign ICU where staff do not speak Arabic are at high risk of post-operative delirium. In our International Medical Wings, we use BIS (Bispectral Index) EEG-guided light anesthesia depth (avoiding deep burst suppression and anticholinergic drugs), dexmedetomidine sleep-cycle preservation, immediate post-extubation return of eyeglasses and hearing aids, and allow a family member and Arabic interpreter at the bedside immediately upon awakening.
3. Zero-Contrast / Iso-Osmolar Renal Protection
For elderly patients with eGFR 25–45 mL/min requiring coronary, aortic, or tumor angiography, our interventional radiologists utilize intravascular ultrasound (IVUS), optical coherence tomography (OCT), carbon dioxide (CO2) digital subtraction angiography, or ultra-low-volume iso-osmolar contrast (Iodixanol) paired with periprocedural intravenous sodium bicarbonate/saline hydration and N-acetylcysteine/TCM renal protection—preventing contrast-induced acute kidney injury.
Essential Cross-Border Medical, Regulatory & Hospital Terminology for GCC Families & Medical Escorts
The highest statutory hospital accreditation awarded by China's National Health Commission, reserved for top national academic referral centers.
Genetic engineering of a patient's T-lymphocytes to recognize and eradicate lymphoma, leukemia, myeloma, solid tumors, or autoimmune B-cells.
Ultra-precise Bragg-Peak particle beam radiotherapy that destroys deep skull-base, liver, pancreatic, and prostate tumors with zero exit dose.
Curative stem cell transplant for Thalassemia Major, Sickle Cell Disease, and Leukemia using a half-matched parent, child, or sibling donor.
Joint consultation bringing together chief surgeons, medical oncologists, radiologists, pathologists, and cellular therapists within 48 hours.
Official financial authorization issued by a GCC Ministry of Health, Embassy Medical Attaché, or international insurer for cashless inpatient care.
China Innovative Oncology Formulary: Next-Generation ADCs, Bispecific Antibodies & Targeted Therapies at 60%–80% Lower Cost
In addition to surgery and CAR-T therapy, China has become a global powerhouse in developing Bispecific Antibodies (simultaneously targeting PD-1/VEGF or PD-1/CTLA-4) and Antibody-Drug Conjugates (ADCs targeting HER2, TROP2, Claudin18.2, EGFR/HER3, and Nectin-4). Many of these breakthrough biologics have outperformed conventional pembrolizumab or chemotherapy in Phase III global trials and are available immediately at our hospital pharmacies at a fraction of US/EU prices, with full customs documentation for patients to bring a 3-to-6-month therapeutic supply back to the Middle East.
| Drug / Biologic Name | Molecular Class & Target | Key Clinical Oncology Indications | China Hospital Pharmacy Reference | US / EU Equivalent Biologic Cost |
|---|---|---|---|---|
| 1. Ivonescimab (依沃西单抗 / AK112) | World's First-in-Class PD-1 / VEGF Bispecific Antibody | 1st-Line PD-L1+ Non-Small Cell Lung Cancer (outperformed Pembrolizumab in HARMONi-2 trial) & EGFR-TKI Progressed NSCLC | ~$950 – $1,250 / Cycle | $11,500 – $15,000 / Cycle |
| 2. Cadonilimab (卡度尼利单抗 / AK104) | World's First PD-1 / CTLA-4 Dual-Immune Bispecific Antibody | Advanced Gastric / Gastroesophageal Junction Adenocarcinoma (even PD-L1 low/negative) & Recurrent/Metastatic Cervical Cancer | ~$880 – $1,150 / Cycle | $14,000 – $18,500 (Nivo+Ipi) |
| 3. Disitamab Vedotin (维迪西妥单抗 / RC48) | High-Affinity HER2 Antibody-Drug Conjugate (ADC) | HER2-Expressing (IHC 2+/3+ or HER2-Low) Locally Advanced/Metastatic Urothelial Bladder Cancer, Gastric Cancer, and Breast Cancer | ~$1,100 – $1,450 / Cycle | $12,500 – $16,000 / Cycle |
| 4. Sacituzumab Tirumotecan (芦康沙妥珠单抗 / SKB264) | Next-Generation TROP2 Antibody-Drug Conjugate (ADC) | Metastatic Triple-Negative Breast Cancer (TNBC) & TKI-Resistant EGFR-Mutant Non-Small Cell Lung Cancer | ~$1,350 – $1,800 / Cycle | $13,800 – $17,200 / Cycle |
| 5. Toripalimab / Sintilimab / Camrelizumab / Tislelizumab | FDA/EMA/NMPA-Approved Humanized PD-1 Monoclonal Antibodies | Nasopharyngeal Carcinoma (FDA #1 standard), Esophageal, Gastric, Hepatocellular, Lung, Colorectal MSI-H, and Hodgkin Lymphoma | ~$280 – $480 / Cycle | $10,800 – $12,500 / Cycle |
| 6. Surufatinib (索凡替尼) & Fruquintinib (呋喹替尼) | Selective Oral VEGFR1/2/3 & FGFR1/CSF-1R Tyrosine Kinase Inhibitors | Pancreatic & Extrapancreatic Neuroendocrine Tumors (NETs) and Refractory Metastatic Colorectal Adenocarcinoma (FDA approved) | ~$620 – $890 / Month | $21,000 – $25,200 / Month |
| 7. Aumolertinib / Furmonertinib / Sunvozertinib (舒沃替尼) | 3rd-Gen CNS-Penetrant EGFR-TKIs & EGFR Exon 20 Insertion Inhibitor | EGFR-Mutant NSCLC with Brain/Leptomeningeal Metastases & Refractory EGFR Exon 20ins Lung Adenocarcinoma | ~$550 – $980 / Month | $16,500 – $22,000 / Month |
| 8. Golidocitinib (戈利昔替尼) & Linperlisib (林普利塞) | Selective JAK1 Inhibitor & PI3Kδ Inhibitor for Lymphoma | Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL), NK/T-Cell Lymphoma, and Follicular Lymphoma | ~$780 – $1,200 / Month | $18,000+ / Month |